Lung Flashcards

1
Q

Community acquired pneumonia

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hospital acquired pneumonia

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Healthcare acquired pneumonia

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ventilator associated pneumonia

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aspiration pneumonia

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Right factors PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Patient population susceptible to PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aspiration PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Local pneumonia

A

Alveoli
CXR/CT-dense consolidation , air bronchospasm

US-consolidation , dynamic air broncograms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Micro of lobar

A

Strep pneumonia

Klebsiella pneumonia

Legionella

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bronchopneumonia

A

Bronchi

CXR/CT-Patchy opacities

US-Patchy B lines

May have consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Micro of bronchopneumonia

A

Wide variety (mycoplasma, chlamydia, staph, pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Interstitial pneumonia

A

Interstitial

CT/CXR-diffuse hazy opacities, septal thickening

US-patchy B lines, may have some consolidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Micro interstitial pneumonia

A

Viruses, PJP, mycoplasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss preventative practices for CAP. What are contraindications

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Two indices used to determine if a patient needs to be admitted to the hospital for PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Outline the following in regards to aspiration PNA and lung abscesses: risk factors, patient presentation, common causative agents, lab findings, imaging, and a generic empiric treatment plan

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Orthomyxovirus PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Adenovirus PNA

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

H5N1 PNA 240, 250

A

Avian flu virus great risk for human pandemics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MPV PNA 303 -paramimyxoviridaevirus

A

Second most common etiology of lower respiratory infection in young.
Upper and lower respiratory tract infections-young kids and old adults

Slightly older as than RSV, 1 year vs 6 months

Winter early spring

Bronchiolitis, croup, pneumonia in kids

Old-cold

Reverse transcriptase PCR

Supportive treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hantavirus PNA 299, 308 a bunyviridae

A

New Mexico, Arizona, Colorado, Utah

Influenza like followed by sudden respiratory failure, lot causing death

In previously health adults

Hemorrhagic fever with renal failure , pulmonary syndrome

Deer mouse-sin nombre south west USA

Pulmonary syndrome-high fever, muscle aches, cough, nausea, vomiting, rapid HR and RR< high WBC, low platelets, elevated RBC

Diagnosis-IgM and IgG to sin nombre

Lung capillary permeability leak-need intubation

40% die

Young adults flu like symptoms who develop pulmonary edema*** just supportive therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Define antigenic drift and shift, provide an example of each

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Outline diagnostic and treatment methods for influenza. Include in you discussion: supportive care and neuraminidase inhibitors

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Strep pneumonia morphology, metabolism, clincial presentation, diagnostics 33, 38

A

Capsule
Smooth S colonies cause rapid death in mice

R-no capsule -lost virluence

India ink stain -no taken up by capsule appears as a transparent halo around the cell. Usually for crypto coccus

Quelling reaction-mixed with antibodies to bind to capsule

Optichin sensitivity

Most common cause of pneumonia in adults

Sudden-shaking chills , high fevers, chest pain with respiration’s, and SOB, alveoli in one or more lung lobes fill up with white blood cells, bacteria and exudate. Seen as white consolidation
Cough up yellow green phlegm
Gram positive lancet shaped diplococci

Most common cause of otitis media in kids and most common bacteria meningitis in adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Haemophilus influenza morphology, metabolism, clincial presentation, diagnostics 96 ,100

A

Rod negative
HACEK

Blood loving, blood again

Hematin found in blood is necessary for the bacterium’s cytochrome system. Blood also contains NAD needed for metabolism

B bad-nonencapsulated strains can colonize UR tract of kids and adults. They lack the virluence invasiveness of their encapsulated cousins and can only cause local infection . Cause otitis media and respiratory disease in adults with weaker prezinsting lung disease

-COPD GET IT worsens wheezing and SOB

Antibodies not in infants 6 mo-3 years, window

B-meningitis , acute epiglottis, septic arthritis, sepsis,

Vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Moraxella 68,71

A

Neisseriaceae

Causes otitis media, and URI in patients with COPD or old

COPD exacerbation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Staph aureus 43, 46

A

Enterotoxin-lipases, penicillinase, staphylokinase, leukocidin, exfoliation, factors that bind complement. Hydrolyzes lipids, destroying penicillins, activates plasminogen to lyse fibrin clots, loses white blood cells, epithelial cell loses,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Klebsiella 75, 94

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Pseudomonas 92, 94

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Coxiella burnetti 120

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Typical pneumonia

A

Strep p, HE< moraxella cat, klebsiella, pseudomonas, coxiella burnetti

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Atypical bacterial pneumonia

A

Mycoplasma, chlamydia pneumonia’s, legionella pneuophilia, chlamydia psittacosaurus, burkholderia cepacia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Mycoplasma pneumonia 156, 158

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Chlamydia pneumoniae 115, 122

A

Atypical bacteria TWAR, which is transmitted from perso to person by the respiratory route and causes an atypical pneumonia in young adults worldwide.

Taiwan and acute respiratory TWAR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Legionella pneumophilia 99-101, 102

A

Aerobic gram negative rod that is famous for causing an outbreak of pneumonia
Pontiac fever, legionnaires disease,

CAP, accounting for .2-10% of all admitted pneumonia cases

Local consolidation , but with fever with pulse temperature dissociation, (high fever, low HR), severe HA, confusion, myalgia, rhabdomyolysis, cough, hyponatremia, diarrhea,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Chlamydia psittacosaurus 115 122

A

Infects 130 species of birds
Human infected by inhaling chlamydia laden dust from feathers or dried out feces. This infection is an occupational hazard for breeders of carrier pigeons, veterinarians, and workers in pet shops or poultry slaughterhouse. Infection most commonly results in an atypical pneumonia called psittacosis, which occurs 1-3 weeks after

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Burkholderia cepacia 93, 94-95

A

Gram negative rods in soil, water, plants, animals, lungs of CF, transmit on medical devices, hands of healthcare workers, between cystic fibrosis, oxidase positive, non lactose fermenter, antibiotic and disinfectant resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Pulmonary fungi

A
Aspergillus
Histoplasma capsulatum
Coccidiodes immitis
Blastomycoses dermatidis
-like Tb inhaled, primary infection int he lung, asymptomatic, mild, severe, or chronic lung infections, lung granulomas, calcifications and/or cavitation, can disseminate hematogenously to distant sites 

Unlike-no person to person, fungi with spores not acid fast bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Aspergillus 201, 2140215

A

Most common allergic bronchopulmonary aspergillosis, aspergillosis, invasive aspergillosis

Inhaling spores -ABPA, increase IgE, eosinophilia
Type IV,

Ppl with lung cavitation form TB can grow an aspergillus call called aspergillosis which needs surgery

Invasive-immunocompromised , bloody sputum may occur, due to blood vessel wall invasion by aspergillus hyphae (neutropenia after chemo or patients on highs teroids AIDS….multiple nodular infiltrateson chest CT, IgG mortality, voriconazole)

Mycotoxin-liver damage called AFLATOXIN…prob since grows in peanuts africa liver cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Histoplasma capsulatum 205-207, 212

A

Non encapsulated
Bird and bat droppings, (chicken cou)
AIDS disseminated \myxelial forms with spores at 25C, yeast at 37, no capsule,

Asymptomatic-most
Pneumonia-lesions calcific, which can be seen onc hest x ray (may look similar to tb)

Disseminated-can occur in almost any organ, espicially in the lung , spleen, or liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Coccidiodes immitis 205-212

A

Mild pneumonia in normal southwest common in AIDS disseminated

Desert, respiratory transmitting

Mycelial forms at 25C, yeast at 37C

Asymptomatic most
Pneumonia
Disseminated-lints, skin, bones, meninges,
-erythema nodosum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Blastomycoses dermatidis 205-207

A

Soil, rotten wood, NOT MILD, weight loss, night sweats, lung involvement, skin ulcers, BBB

Mycelial forms 25 years 37

Asymptomatic-most
Pneumonia-lesions rarely calcify
Disseminated-present with weight loss, night sweats, lung involvement and skin ulcers
Cutaneous-skin ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Harrisons 132 pneumonia Nd lung abscess,

101 influenza and other common viral respiratory infections

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is pneumonia

A

Infection of lung parenchyma, classified as community acquired (CAP) or health care-associated (HCAP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

HCAP

A

Hospital acquired and ventilator associated

Associated with current hospitalization for >48 h, hospitalization for > 2 days in the prior 3 months, chronic dialysis, home infusion therapy, home wound care, and contact with a family member who has multi drug resistant infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

How get pneumonia

A

Microorganisms gain access to the lower respiratory tract via microaspiration fromt he oropharyngeal (most common), inhalation of contaminated droplets, hematogenous spread , or contiguous extension from an infected pleural or mediastinal space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Before disease manifests, the size of the organism burden must overcome the ability of ___and other components of innate immunity (surfactant proteins A and D) to clear bacteria

A

Macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Classic pneumonia presentation

A

Step p

Lobar pattern and evolves through four phases characterized by changes int he alveoli
Edema: proteinaceous exudates are present
Red hep-erythrocytes and neutrophils are present int he intraalveolar exudate
Gray hep-neutrophils and fibrin deposition are abundant
Resolution-macrophages are the dominant cel type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

In VAP, respiratory bronchiolitis can __ a radiographically apparent infiltrate

A

Precede

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Typical community acquired pneumonia

A

S pneumoniae, haemophilus influenza, staph aureus, and gram negative bacteria like klebsiella p and pseudomonas a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Atypical PNA

A

Mycoplasma pneumoniae, chlamydia pneumoniae, legionella, respiratory viruses (influenza, adenovirus, human metapneumovirus, RSV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

A virus may be responsible for a large proportion fo CAP cases that require ____, even in adults

A

Hospital admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

10-15% of PNA are ___

A

Polymicrobial

Combo of typical and atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

When do anaerobes play a big role in CAP

A

Aspiration precedes presentation by days or weeks, often results in significant empyema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

CAP epidemiology

A

> 5 million a year in US, 80% treated outpatient

> 55000 deaths annually

12 billion dollars

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Who gets CAP most

A

<4 >60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Risk factors CAP

A

Alcoholism, asthma, immunosuppression, institutionalization, >70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Factors CPA

A

Tobacco smoke, copd, colonization with MRSA, recent hospitalization or antibiotic therapy-influence the types of pathogens that should be considered in etiology disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Clincial manifestation CAP

A

Fevers, chills, sweat, cough, pleuritic chest pain, dyspnea

Nausea, vomiting, diarrhea, fatigue, HA< myalgia, arthralgias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Old patients with CAP presentation

A

Atypical, with confusion but few other manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

PE CAP

A

Tachypnea, increased or decreased tactile fremitus; dull or flat percussion reflecting consolidation and pleural fluid, respectively; crackles; bronchial breath sounds ; pleural friction rub

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Diagnose CAP-want bc empiric tratment better for specific , also public safety implications

A

Chest radiography (need sensitivity and specificity not perfect from PE)

  • CT for postobstructive PNA or suspected cavitary disease
  • some radiographically patterns suggest an etiology (pneumatoceles suggest s aureus)

Sputum samples must have WBC>25 and <10 squamous epithelial cells per high-power field to be appropriate for culture. The sensitivity of sputum cultures is highly variable; in cases of proven bacteremic pneumococcal pneumonia, the yield of positive cultures form sputum samples<50%

Blood cultures are positive in 5-14% of cases, most commonly yielding s pneumoniae. Blood cultures are optional for most CAP pots but should performed for high risk pts (pts with chronic liver disease or asplenia)

Urine antigen tests for S pneumiae and legionella pneumophila type 1 can be helpful

PCR of nasopharyngeal swabs has become the standard for diagnosis of respiratory viral infection and is also useful for detection of many atypical bacteria

Serology: a fourfold rise in titer of specific IgM antibody can assist in diagnosis of pneumonia due to some pathogens; however, the time required to obtain a final result makes serology of limited clincial utility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What are the two sets of criteria that identify pts who will benefit from hostpail care

A

Pneumonia severity index

CURB-65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Complications CAP

A

Respiratory failure, shock, multiorgan failure, coagulopathy, and exacerbation of comorbid disease. Metastatic infection occurs rarely and requires immediate attention

-lung abscess may occur in association with aspiration or infection from single CAP pathogen (P. Aeruginosa).

Any significant pleural effusion should be tapped for diagnostic and therapeutic purposes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Pleura effusion pH<7, glucose<2.2 LDH >1000 or if bacteria seen or cultured

A

Fluid should be drained, a chest tube is usually required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Follow up CAP

A

CXR abnormalities may require 4-12 weeks to clear. Pts should receive influenza and pneumococcal vaccines, as appropriate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Ventilator associated pneumonia micro

A

Potential etiology agents include MDR and non MDR pathogens; the prominence of various pathogens depends not he lengthof hospital stay at the time of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Epidemiology VAP

A

-26-52 cases per 100 pts, with the highest hazard ration in the first 5 days of mechanical ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Three factors important in the pathogenesis of VAP

A

Colonization of the oropharynx with pathogenic microorganisms, aspiration of these organisms to the lower respiration tract, and compromise of normal host defense mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Clincial manifestation

A

Are similar to those in other forms of pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Diagnosis VAP

A

Application of clinical criteria consistently results in overdiagnsis of VAP. Use quantative culture to discriminate between coloniazation and true infection by determining bacterial burden may be helpful; the more distal int he respiratory tree the diagnostic sampling, the more specific the results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What if use wrong treatment

A

Higher mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Treatment failrue VAP

A

Common, espicially MRSA, P aeruginos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

VAP complications

A

Prolonged mechanical ventilation, increased length of ICU stay and necrotizing pneumonia with pulmonary hemorrhage or bronchiectasis. VAP is associated with significant mortality risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Hostpital acquired pneumonia

A

MDR usually
Anaerobes may also be more commonly involved in non-VAP pts bc of the increased risk of macro aspiration in pts who are not incubated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Bronchiectasis etiology

A

Irreversible airway dilation that involves the lung in either a focal or a diffuse manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Epidemiology bronchiectasis

A

Older age women

25-50% idiopathic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Vicious cycle of bronchiectasis

A

Susceptibility to infection and poor mucocele are clearance results in microbial colonization of the bronchial tree.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Noninfections bronchiectasis

A

Immune mediated reactions that damage the bronchial wall and parenchymal distortion as a result of lung fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Clinical manifestation bronchiectasis

A

Persistent productive cough with ongoing production of thick, tenacious sputum

Crackles and wheezing on lung auscultation and occasionally reveals clubbing

Acute exacerbations are associated with increased purulent sputum production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Diagnose bronchiectasis

A

Clincial presentation with consistent radiographically findings such as parallel tram tracks a signet ring sign, lack of bronchial tapering, bronchial wall thickening or cysts emanating from bronchial wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Treat bronchiectasis

A

Control of active infection and at improving in secretion clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Lung abscess what is it

A

Necrosis and cavitation of the lung following microbial infection -can be categorized as primary )80%) or secondary; alternatively, it can be categorized as acute (<4-6 weeks in duration) or chronic (40%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What causes primary lung abscesses

A

Usually arise from aspiration int he absence of an underlying pulmonary or systemic condition, are often polymicrobial (primarily including anaerobic organisms and microaerophilic streptomcin) and occur preferentially in dependent segments (posterior upper and superior lower lobes) of the right lung.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Secondary cloud abscesses

A

In setting of underlying condition (post obstructive process, an immunocompromised condition) and can be due to a number of different organisms among which P aeruginosa and other gram negative rods are most common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Clinical manifestations lung abscess

A

Similar to pneumonia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Anaerobic lung abscess presentation

A

More chronic and indolent presentation, with night sweats, fatigue, and anemia, in addition, pts may have discolored phlegm and foul tasting or foul smelling sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Lung abscess from non anaerobic organisms (s aureus)

A

Present with a more fulminant course characterized by high fevers and rapid progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Diagnose lung abscess

A

Chest CT is the preferred radiographically study for precise delineation of the lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Secondary lung abscess diagnosis

A

Sample collection (lovage, CT guided percutaneous aspiration) are recommended for secondary lung abscesses or when empirical therapy fails

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Treat primary lung abscess

A

Clindamycin or amoxacilllin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

Secondary lung abscess treat

A

Specific pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

When stop treat lung abscess

A

When cleared or small scar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Influenza A< B, C

A

Viruses RNA and orthomyxoviridae that have different nucleoprotein and matrix protein antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Major human influenza

A

A and B (morphologically similar)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

A or B more severe

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Influenza A subtypes by ___ and ____

A

Hemagglutinin(H) and neuraminidase(N) antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

How does influenza infect

A

Attaches to Salic acid cel receptors via the hemagglutinin.neuraminidase degrades the receptor and plays a role in the release of virus from infected cells after replication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

What is major determinant of influenza a immunity

A

H antigen antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

N antibodies

A

Limit viral spread and contribute to reduction of the infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

How influenza a acquired

A

Aerosolized respiratory secretions of acutely ill individuals and possibly by hand to hand contact or other personal or fomoterol contact. Viral shedding usually stops 2-5 days after disease onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Epidemiology influenza A

A

Each year an vary in extent/severity

Winter. In temperate climates

Year round in tropics

Epidemics begins abruptly, peak over2-3 weeks, last 203 months, and then subside rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Global pandemics

A

2009 A H1N1

Multiple locations, high attack rates, beyond normal seasonality patterns, and are duein part to the propensity of the H and N antigens to undergo periodic antigenic variation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Major changes

A

Antigenic shirt (INFLUENZa a only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Minor variations

A

Antigenic drifts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Avian influenza virus A/H51

A

Cause sporadic human cases, but sustained human to human transmission has not been observed; infection is linked to direct contact with infected poultry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

Swine

A

Can sustain simultaneous infection with swine, human, and avian

Thesis multiple. Virus infections facilitate reassortment of genetic segments of different viruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

Pandemic A/H1N1 virus 2009-2010

A

Quadruple reassortment among swine, avian and human influenza viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Interpandemic outbreaked

A

226,000 hospitalizations and 23,000 deaths per year in US. Chronic cardiopulmonary disease and old age are the most prominent risk factors for severe illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

Clincial manifestation influenza

A

Mild cold like, abrupt HA< fever, chills, myalgia, malaise

Deserves every within 2-3 days, but respiratoy symptoms accompanied by sub sternal pain can persist for >1 week. Postinfluenza asthenia may persist for weeks, particularly int he elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Complications influenza

A

Pneumonia and extrapulmonary

Common patients under 5 and over 65, pregnant women, or patients with chronic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Pneumonia from influenza

A

Primary influenza pneumonia is the least OMMonday but most severe of the pneumonic complications, most often affecting patients with mitral stenosis and pregnant-pts with progressive pulmonary disease and high timers of virus in respiratory secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Secondary bacterial pneumonia

A

Usually due to strep pneumoniae, strep aureus, or haemophilus influenza and presenters as the reappearance of fever ANS respiratory symptoms after 2-3 days of clinical improvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Most common pneumonic complication involves aspects of viral and bacterial pneumonia

A

Extrapulmonary complications : Reyes’s, myositis, rhabdomyolysis, myoglobinuria, and CNS disease can occur as complications of influenza infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Reye’s syndrome

A

Serious complication in children that is associated with influenza B virus (and less commonly wth influenza A virus), varicella zoster virus, and asprin therapy for the antecedent viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

Diagnose influenza

A

Reverse transcription PCR of respiratory samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Rapid tests that detect viral antigens

A

Fast results, can distinguish influenza a and b viruses, and are relatively specific but variably sensitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

Serologic testing

A

Requires availability of acute and convalescent phase sera and is useful only retrospectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Prophylaxis influenza

A

Annual vaccination with either an inactivated or a live attenuated vaccine is the main public health measure for prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

How make vaccine

A

Strains are generated from influenza a and b viruses that have circulated during the previous influenza season and whose circulation during the upcoming season is predicted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

Inactivated vaccines

A

50-80% protection against influenza is expected if the vaccine virus and the currently circulating viruses are closely related

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Who gets influenza vaccine

A

> 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

Chemoprophylaxis against influenza

A

Should be reserved for individuals at high risk of complications who have had close contact with a pt sick with influenza. Chemoprophylaxis can be administered simultaneously with inactivated-but not with live-vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

Acute viral respiratory illness

A

> 50% of all acute illnesses; adults have 3-4 cases per person per year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Clincial presentation acute viral respiratory illness

A

Not specific enough to allow an etiology diagnosis, and viral illnesses are typically grouped into clinical syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

Microbiology rhinovirus

A

Non enveloped, SsRNA viruses int he family picornaviridae that together are the major cause of the common cold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

Epidemiology rhinovirus

A

Spread by direct contact with infected secretions, usually respiratory droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

Clinical manifestations rhinovirus

A

After an incubation period of 1-2 days, pts develop rhinorrhea, sneezing, nasal congestion and sore throat that lasts for 4-9 days. Fever and other systemic signs and symptoms are unusual in adults.
-severe disease, including fatal pneumonia, is rare but has been described in immunocompromised pts, particularly bone marrow transplant recipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

Diagnose rhinovirus

A

PCR and tissue availbe, but not ususlal attempted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

Treat rhinovirus

A

Symptom-antihistamines and decongestants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

Coronovirus

A

Pleomorphic, SsRNA viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

What coronavirus cause

A

Common cold SARS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

Incubation period coronavirus and duration

A

3 days

6-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

2002-2003

A

Coronavirus SARS developed in >8000 pts in 28 countries and was associated with 10% fatality rate, no case since 2004

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

SARS incubation period and duration

A

2-7 days after which patients develop fever, malaise, HA< myalgia, and then a nonproductive cough and dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

SARS patients can develop what in second week of illness

A

ARDS and multiorgan dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

Middle East respiratory syndrome coronavirus

A

First identified in 2012 and has caused more than 1600 cases, with a 36% case fatality rate. All cases have been associated with contact or travel to the Arabian peninsula
-after an incubation period of 5 days, patients develop cough and fever that progress to respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Diagnose coronavirus

A

ELISA, IF< reverse transcription PCR

SARS and MERS detected by R-PCR or viral culture of respiratory samples

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

Treat coronavirus

A

Common cold-symptom relief

SARS MERS-aggressive supportive care is most important . No specific therapy has been established as efficacious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

Human respiratory syncytial virus

A

Enveloped SsRNA and a member of the paramyxoviridae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

Epidemiology HRSV

A

With an attack rate approaching 100% among susceptible individuals, HRSV is a major respiratory pathogen among young children (2-3 months) and the foremost cause of owner respiratory disease among infants

-30-35% of hospital admissions of young children for pneumonia and for 75% of cases of bronchiolitis in this age group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

Transmission HRSV

A

Contact with contaminated fingers or fomites and by spread of coarse aerosols. Incubation 4-6 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Clincial manifestation HRSV

A

Infants typically develop rhinorrhea, low grade fever, cough, and wheezing; 35-40% of infections resul in lower tract disease, including pneumonia, bronchiolitis and tracheobronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

In adults HRSV typically presents as the common cold, but is can cause

A

Lower respiratory tract disease with fever, including severe pneumonia in patients who are elderly or immunosuppressed or who have cardiopulmonary disease. HRSV pneumonia has a case-fatality rate of 20-80% among transplant pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

Diagnosis HRSV

A

Rapid viral diagnosis available IF, ELISA, RTPCR of nasopharyngeal washes, aspirates or swabs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

Treat HSRV

A

Symptom based for upper tract disease and mild lower tract disease

Incubation-if severe lower tract disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

Prevention HRSV

A

Monthly give palivizumab <3 years old who have bronchopulmonary dysplasia or cyanosis heart disease or who were born prematurely. In settings with high transmission rates, contact precautions are useful to limit spread of the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

Human metapneumovius

A

Pleomorphic, single stranded RNA virus of the family paramyxoviridae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

Epidemiology Human metaneumovirus

A

1-5% of childhood upper respiratory tract infections and for 2-4% of acute respiratory illnesses in ambulatory adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

Clincial human metapneumovirus

A

Disease manifestations are similar to those caused by HRSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

Diagnose human HRSV

A

IF, PCR< tissue culture of nasal aspirates or respiratory secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

Treat human metapneumovirus

A

Supportive and symptom based

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

Parainfluenza virus

A

Enveloped SsRNA virus of the family paramyxoviridae ranks second only to HRSV as a cause of lower respiratory tract disease among young children and is the most common cause of croup (laryngotracheobronchitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

Clinical manifestations parainfluenza virus

A

Infections are milder among children and adults, but severe , prolonged and fatal infection has been reported among pts with severe immunosuppression, including transplant recipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

Diagnosis paramyxoviridae

A

Infections are milder among children and adults but severe prolonged and fatal infection has been reported among pts with severe immunosuppression, including transplant recipients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

Diagnoses paramyxoviridae

A

Tissue culture, rapid testing with immunofluorescence or ELISA (both of which are less sensitive) or PCR of respiratory tract secretions, throat swabs, or nasopharyngeal washing can detect virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

Treat parainfluenza virus

A

Treat URI symptom based.

For cases of croup with respiratory distress, intermittent racemis epinephrine and glucocorticoids are beneficial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

Adenovirus

A

DsDNA virus 10% of acute respiratory infections among children and <3% of respiratory illness among civilian adults. Some serotypes are associated with outbreaks among military recruits. Transmission takes place primarily from fall to spring cia inhalation of aerosolized virus through inoculation of the conjunctival spaces, and probably via the fecal oral route

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

Clincial adenovirus

A

In children, causes upper and lower respiratory tract infections and outbreaks of pharyngojunctical fever

Adults-type 4 and 7 cause an acute respiratory disease consisting of a prominent sore throat, fever on the second or third day of illness, cough, Cory a, and regional adenoma they. Pharyngeal edema and tonsillar hypertrophy with little or no exudate may be seen

In addition to respiratory disease, adenovirus can cause diarrheal illness, hemorrhagic cystitis and epidemic keratoconjuctivitis. In patients who have received a solid organ transplant, adenovirus can affect the transplanted organ and disseminate to other organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

Diagnose adenovirus

A

Isolation fo the virus in tissue culture; by rapid testing of nasopharyngeal aspirates, conjunctival or respiratory secretions, urine, or stool, or by PCR testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

Treatment adenovirus

A

Supportive ribavirin cidofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

Tb Harrison

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

Compare and contrast primary , progressice primary, latent and active Tb

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

Outline signs and symtpoms indicative of pulmonary Tb

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

Outline lab findings that are consistent with M Tb

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

Familiarize yourself with PPD skin testing, place emphasis on interpreting results, how the BCG vaccination affects PPD skin testing, and highlights false negative and false positive test results

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

Table 94-2

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

Describe imaging finding for primary Tb, active Tb, and Millard Tb

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

Define a nervy and discuss which patient populations are most likely to exhibit this phenomenon

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
171
Q

Outline basic principles of anti Tb treatment, outline the 5 drugs used for the initial treatment of Tb . Include in your discussion potential side effects of each drug

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
172
Q

In regards to monitoring treatment of TB, outline labs that are used to assess treatment progression and potential AE of medication

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
173
Q

Define MDR-TB and XDR TB

A

List reasons for resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
174
Q

Mycobacterium TB

A

Acid fast
Mycotic acid, mycoside, cord factor , sulfatides, wax D MIKE WAX SURF CORD

Facultative intracellular growth in macrophages, cell mediated immunity, caseous necrosis

PPD skin test, type IV, (false positive BCG)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
175
Q

Mycobacterium Adium complex

A

AIDS-disseminated infection with fever, weight loss, hepatitis, and diarrhea

Immunocompromised-upper lung cavitary disease in elderly smokers, middle and lower lung nodular and bronchiectasis disease in middle aged femalenon smokes

Lymphadenitis-most commonly in kids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
176
Q

Mycobacterium kansaii

A

Gram positive acid fast, obligate aerobes, facultative intracellular organisms,

Pulmonary: upper lung cavitary disease
Disseminated disease in immunocompromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
177
Q

Microbiology TB

A

Caused by organisms of the mycobacterium TB complex, which includes M Tb, most common and important agent of human mycobacteria disease, and M Boris, which is acquired via ingestion of unpasteurized milk. M Tb is a thin aerobic bacillus that is neutral on gram staining but that nice stained is acid fast. It cannot be decolonized by acid alcohol bc th cell walls high content of molecules acids and other lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
178
Q

Epidemiology TB

A

9 million new cases every year 1.5 million deaths-usually glow income, TB stable and falling worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
179
Q

US T

A

HIV, immigrants, old, poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
180
Q

MDR M TB

A

Resistant o at least rifampin and isoniazid and extensively drug resistant are increasing in frequency=480000 causes in 2013

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
181
Q

How spread T

A

Droplet nuclei that are aerosolized by coughing, sneezing or speaking
<5-10 microV in diameter may be suspended in air for several hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
182
Q

How determine intimacy of Tb and duration of contact with pt

A

Degree of infectiousness of the pt, and the shared environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
183
Q

Cavitary or laryngeal disease

A

Most infectious, with as many as 10^5-10^7 acid fast bacilli in sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
184
Q

Risk factors for active TB

A

Recent acquisition, comobidity (HIV..), malnutrition, tobacco smoking, and presence of fibrotic lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
185
Q

Pathogenesis T

A

AFB that reach alveoli are ingested by macrophages. The bacilli impair phagosome maturation, multipl, lyse the macrophages, and spread to regional lymph nodes, reform which they may disseminate thought the body. Thesis initial stages of infection are generally asymptomatic and induce cellular and humoral immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
186
Q

2-4 weeks after Tb infection

A

A tissue damaging response resulting from delayed hypersensitivity destroys nonactivated macrophages that contain multiplying bacilli, and a macrophage activating response activates cells capable of killing AFB. A granuloma forms at the site of the primary lesion and at sites of dissemination. The lesions can then either heal by fibrosis or undergo further evolution. Despite helping, viable bacilli can remain dormant within macrophages or in necrotic material for years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
187
Q

______ confers partial protection against BT. Cytokines secreted by alveolar ___c ontribute to disease manifestations, granula formation and mycobacteria killing

A

Cell mediated immunity

Macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
188
Q

Clinical T

A

Pulmonary, extrapulmonary or both

Extrapulmonary higher in HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
189
Q

Pulmonary TB primary disease

A

No or mild in contrast to prolonged disease course that is common in post primary or adult type

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
190
Q

Primary Tb disease

A

Middle and lower lobes. Heal spontaneously, and calcified nodule (GHON FOCUS) remains

  • transient hilar and paratracheal lymphadenopathy is common
  • in immunosuppressed pts and children, primary disease may progress rapidly to significant clincial disease, with cavitation, pleural effusions and hematogenous dissemination (military)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
191
Q

Military disease

A

Hematogenous dissemination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
192
Q

Adult type TB

A

Initially with nonspecific and insidious signs and symptoms such as diurnal fever, night sweats, weight loss, anorexia, malaise, and weakness

  • as progresses get cough, pursuant sputum with blood streaking, extensive cavitation may develop, with occasional massive hemoptysis following erosion of a vessel located int he wall of a cavity
  • disease is usually localized to the apical and posterior segments of the upper lobes and superior segments of the lower lobes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
193
Q

Extrapulmonary T

A

Any site, usually lymph nodes, pleura, GU, bones, joints, meninges, peritoneum, and pericardium,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
194
Q

HIV and T

A

2.3 have extrapulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
195
Q

Lymphadenitis T

A

35% extrapulmonary, esp in kids and HIV infected pts. Painless swelling of cervical and supraclavicular nodes (scrofula)

  • nodes are discrete early on but can develop into a matter nontender mass with a fistulas tract
  • fine needle aspiration or surgical excision biopsy of the node is requires for diagnosis. Cultures are positive 70=80%.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
196
Q

Pleural TB

A

20% extrapulmonary, from hypersensitivity response to mycobacteria antigens or contiguous spread of parenchymal inflammation

  • pleural fluid is straw colored and exudative, with protein levels >50% of those in serum, normal to low glucose, and pH 7.3, and pleocytosis, the pleural concentration deaminase, of low, virtually excludes
  • empyema is uncommon from rupture of a cavity with many bacilli into the pleural space. In these cases, direct smears and cultures are often positive, and surgical drainage us usually required in addition to chemo
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
197
Q

GU T

A

Local symptoms predominate and 75% have a CXR with previous or concomitant pulmonary disease. Occasionally identified only after severe destructive lesions of kidney have developed.

  • UA pyuria and hematuria with negative bacterial cultures
  • mycobacteria culture of three morning urine specimens is diagnostic 90%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
198
Q

Weight bearing joints T

A

Most common spinal T(Potts)-often involves two or more adjacent vertebral bodies; in adults , lower thoracic/upper lumbar vertebrae are usually affected. Disease spreads to adjacent vertebral bodies, later affecting the intervertebral disk and causing collapse of vertebral bodies in advanced . Paravertebral cold abscess

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
199
Q

Meningitis T

A

Kids and HIC,
1-2 weeks with paresis of CN, toward coma, with hydrocephalus and ICP high
-CSF can have high lymphocyte count an elevated protein level and a low glucose concentration. Cultures are positive in 8% of cases. PCR sensitive!!!!!
-glucocorticoids enhance survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
200
Q

GI Tb

A

Can affect any portion of GI , ab pain, obstruction, hematochezia, palpable mass, peritonitis from ruptures lymph nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
201
Q

Pericarditis Tb

A

Acute or subacute onset of fever, dull retrosternal pain and friction rub, effusion common, chronic is potentially fatal,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
202
Q

Military disease

A

Hematogenous spread of M Tb through body. Small granulomas may develop in many organs. Hepatomegaly, splenomegaly, lymphadenopathy, and choroidal tubercles of eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
203
Q

HIV associated TB

A

Partial Cell mediated compromised-typical upper lobe

Late HIV-diffuse interstitial or Millard infiltrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
204
Q

Immune reconstitution inflammatory syndrome

A

1-3 mo after initiation antiretroviral, may exacerbate TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
205
Q

Diagnose TB

A

AFB microscopy stained with Ziehl Neelsen basic fuchsin dyes of fluoresce microscopy of samples stained with auramine rhidamine-can provide a presumptive diagnosis in TB , two or three sputum samples need

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
206
Q

Definitive diagnosis

A

Grow M Tb in culture or identification or the organisms DNA in clinical samples
-liquid media and speciation by molecular methods have decreased the time required for diagnostic confirmation 2-3 weeks

Nucleus acid amplification in AFB pos and neg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
207
Q

TST

A

Limited value active disease but mist widely used screening test for latent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
208
Q

Interferon gamma release assays

A

Measure the release of interferon gamma by T cells after stimulation with TB specific antigens and more specific for M Tb that TST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
209
Q

Prevent T

A

Vaccination

Treat latent infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
210
Q

Tuberculin reaction size >5

A

HIV infected, recent contacts of a patient with TB , organ transplant recipients, persons with fibrotic lesions consistent with old TB on chest radiography, immunocompromised, persons with high risk medical conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
211
Q

Tuberculin reaction size >10 mm

A

Recent immigrants from high prevalence coutnries, injection drug users, mycobacteriology laboratory personnel; residents and employees of high risk congregate settings, children under 5, low risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
212
Q

Leprosy

A

Nonfatal chronic infectious disease from m leprae, an obligate intracellular bacterial species indistinguishable microscopically from other mycobacteria. In humans, armadillos, and sphagnum moss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
213
Q

Can you culture M leprae

A

Not in vitro, has a doubling time in mice of 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
214
Q

What is leprosy associated with

A

Poverty and rural residence, is a disease of developing world; its global prevalence is difficulty to assess and is variously estimated at .6-8 million
-400 in america

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
215
Q

Transmission leprosy

A

Nasal drops maybe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
216
Q

Clinical leprosy

A

Polar tuberculoid to polar lepromatous disease is associated with an evolution from asymmetric localized Manuel’s and plaques to nodular and infuriated symmetric generalized skin manifestations, an increasing bacterial loss and loss of M leprae-specific cellular immunity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
217
Q

Incubacliniincubation leprosy

A

2-40 years, usually 5-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
218
Q

Tuberculoid leprosy

A

At the less severe end of the disease spectrum, TT leprosy results in symptoms confined to the skin and peripheral nerves ,

  • one or several hypopigmented macules or plaques with sharp margins that are hypesthetic and have lost sweat glands and hair follicles are present. AFB are few or absent
  • there is asymmetric enlargement of one or several peripheral nerves-most often the ulnar, posterior auricular, peroneal and posterior tibial nerves-associated with hypesthesia and myopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
219
Q

LL leprosy

A

Pts develop symmetrically distributed skin nodules, raised plaques and diffuse dermal infiltration that can cause leonine fancies, loss of eyebrows and lashes, pendulous earlobes and dry scaling

  • numerous bacilli are present in skin, nerves, and all organs except the lungs and CNE
  • nerve enlargement and damage are usually symmetric and due to bacillary invasions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
220
Q

Complications leprosy

A

Reactional states-immune mediated inflammatory states(can be deadly)
-erythema nodosum -painful erythematous papules that resolve spontaneously in 1 week

Extremities-neuropathy (insensitive to stuff, and LOSE distal digits as result),

Eyes-CN palsies, legophthalmos and corneal insensitivity may complicate …blindness
Nerve abscess-urgent surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
221
Q

Diagnosis TT

A

Biopsy, even in normal skin

Others not good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
222
Q

What are nontuberculous mycobacteria

A

Mycobacteria not Tb or leprosy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
223
Q

Miepidemiology NTM

A

Cause disease in humans only rarely unless some aspect of host defense impaired

Mainly M kansasii, MAC M abscesses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
224
Q

Clincial manifestations NTM

A

Broad

Dieesminated
Pulmonary disease
Isolated cervical lymphadenopathy
Skin and ST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
225
Q

Disseminated NTM

A

Rare, HIV, spread from bowel to the bone marrow and bloodstream, but disease is indolent, and it can take weeks or months for the pt to present for medical attention with malaise, fever, weight loss, organometallic, and lymphadenopathy, >3 organ systems should be evaluated for interferon y pathway defect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
226
Q

Pulmonary NTM

A

Industrialized
MAC in North America
Present with months or years of throat clearing, nagging cough, and slowly progressice fatigue. M kanassii can cause a TB like syndrome with hemoptysis, chest pain and cavitary lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
227
Q

Isolated cervical lymphadenopathy NTM

A

Most common in kids in NA, MAC

Nods typically firm and painless and develop in absence of systemic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
228
Q

Skin ST NTM

A

Requires break in skin for introduction of organisms. Different NTM associated with exposures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
229
Q

M fortuitous

A

Lined to pedicure bath-skin abrasions has imediatde pedicure (like if shaved legs before pedicure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
230
Q

M marinum

A

Acquires from fish tanks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
231
Q

M ulverans

A

Waterborne tropical and africa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
232
Q

Diagnose NTM

A

Acid fast or fluorocarbons smears of clincial samples and cultured on mycobacteria medium. Isolation of NTM from a clincial specimen may reflect colonization and requires an assessment of the organisms clincial significance

Isolation of NTM from blood specimens is clear evidence of disease; many NTM species require special media and not grown on blood culture medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
233
Q

MAC

A

Two of three sputum samples, a positive lovage, or a pulmonary parenchyma biopsy with granulomatous inflammation or mycobacteria found on section and NTM in culture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
234
Q

Antibiotic NTM

A

Clarromycin, MAC

Kansassi-rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
235
Q

MAC

A

Macrolides bc MDR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
236
Q

Kansassi

A

Isoniazid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
237
Q

M Mary I’m

A

Rifamycin treat extrapulmonary disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
238
Q

Pulmonary htn

A

Describe the common cause of pulmonary HTN

Outline clinical findings of patients with pulmonary HTN, and describe the basis for assigning patients to a group

Describe common management principles in patients with pulmonary HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
239
Q

Medication induced pulmonary HTN

Fen-phen, the weight loss drug that suppresses appetites

A

Releases serotonin

Fatigue dizzy, SOB, primary pulmonary HTN, idiopathic pulmonary arterial HTN, heart valve disease, HF

Causes pulmonary HTN and heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
240
Q

.smoker, normal vitals, but low O2 sat. , bibasilar inspiratory crackles. No wheeze or prolongation of the expirations phase, no neck vein distention. S4

A

Normal vitals but low o2, has crackles, has s4 gallop

Hypovascularoty peripheral
Right descending pulmonary artery
prominent central artery
RV enlargement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
241
Q

X ray of PAH

A

Peripheral hypovascularity, prominent central pulmonary artery (right and left prominent), right descending pulmonary artery, RV enlargement(see on lateral)-from increased workload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
242
Q

Classic PFT pulmonary HTN

A

May have features of primary cause -severe COPD low DLCO

Low diffusion capacity for CO….

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
243
Q

Classis PAH with no DLCO

A

Normal PFT except isolated reduction in DLCO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
244
Q

ECG PAH

A

RVH, RV strain, RAD

Right axis deviation, right ventricular hypertrophy

May see peaking of p wave—-right atrial enlargement .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
245
Q

Echo PAH

A

Increased estimated PA pressure

RA enlargement
RV enlargement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
246
Q

Is pulmonary HTN common

A

Pretty common

Idiopathic uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
247
Q

Treat pulmonary HTN

A

Treatment is the treatment of underlying disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
248
Q

Idiopathic HTN is common?

A

No…specific therapies are changing very rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
249
Q

Group 1 pulmonary HTN

A

Idiopathic and CTD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
250
Q

Group 2 pulmonary HTN

A

Heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
251
Q

Group 3 pulmonary HTN

A

Lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
252
Q

Group 4 pulmonary HTN

A

Pulmonary emboli

253
Q

Group 5 pulmonary HTN

A

All others

254
Q

Similarities between pulmonary HTN and ischemic heart disease

A

Both have exertional dyspnea, similar lack of associated symptoms, BNP elevated

255
Q

Differences between pulmonary HTN and ischemic heart disease

A

P2 increased in PAH

CXR

Other studies-ECG, echo
-ischemic, congestion, Kelley b lines, increased vasc
May not see vascularity in pulmonary HTN

256
Q

Functional assessment of PAH

Soo, how diagnose PH, how treat

A

6MWT

Serial testing
-echo, right heart cath

-echo, ekg large RA, RV, but need right heart cath over 40mmHg.
P2 loud
-idiopathic, vasodilator 
-other treat cause 
Stop med
Oxygen-why do 6MWT
257
Q

OSA history clues

A

Impaired daytime attention
-MVA, diffulty with memory, sleepiness

Snoring

Witnessed apnea

Mood alterations
-obese patients with depression must be screened for OSA

1/4 have complaints of this

258
Q

Clincial findings OSA

A

Obesity, large neck circumference (short road), nasal obstruction( talk weird, short airway polyps and stuf congested), enlarged tonsils, narrow oropharynx, macroglossia, micrognathia, retrognathia

259
Q

Can non obese people get OSA. How diagnose OSA

A

Yup

Sleep history from parter and patient, morning headaches, fat, postmenopausal women,

Need ****polysomnography(measures respiratory events and hours of sleep to derive the apneahypopnea index, which is the average number of apnea and hypoapnea events per hour >5 per hour confirms OSA) for diagnosis, may get electroencephalogram for sleep staging and assessment to accurately diagnose.

260
Q

Manage OSA goals

A

Improve daytime sleepiness and cognitive performance, prevent long term sequelae

Improve mood and depressive symptoms, higher quality of life, lower incidence of traffic accidents, decrease daytime sleepiness

Improved quality of life

261
Q

Tools to manage OSA

A

Lifestyle modifications, CPAP

262
Q

Long term sequelae

A

Patients with moderatesevere OSA are
-four times more likely to die each year than non affected patients

  • 2.5 times more likely to develop cancer
  • four times more likely to have a CVA

——get serum TSHwith recent weight gain it may be elevated), chest x ray for heart failure, ECG for heart failure, COC secondary erythrocytosis can be a complication of severe OSA with hypoxemia, overnight oximetry , arterial blood gas to OHS),

263
Q

Lifestyle modifications OSA

A

Obese? Lose 10% or more

Avoid etOH and sedatives 3-4 hrs prior to bed

Lateral decubitus sleeping position (keep airways from collapsing)

Intranasal steroids/decongestants-can help congestion

264
Q

When give CPAP

A

If symptoms persist after modifications

Pneumatically props airway open
-increased intraluminal airway presssure and FRC-after modifications

Defer driving

Continuous positive atrial airway pressure ,

265
Q

What is don’t adjust to CPAP

A

Bi-level PAP (BiPAP)

CPAP has one pressure level; BiPAP has separate pressures for inspiratory and expiratory phases…may improve comfort and adherence

Bi level positive airway pressure nasal ventilation or auto titrations positive pressure devices that modify airflow pressure to a more comfortable level.

266
Q

Oral device OSA

A

Mandibular assist device

  • can eliminate need for CPAP in mild/moderate cases
  • protrudes the jaw and/or holds tongue forward to prevent prolapse
267
Q

Upper airway surgery OSA

A

If cant use CPAP, resection of enlarged obstructing tonsils may be beneficial ,
-get fibrosis and things retract and enlarge more

Uvulopalatopharyngoplasty (UPPP)-Respect tonsils and adenoids, make small airway larger

  • aleviate obstruction of the hypoglossal space.
  • can remove obstruction to airflow
  • patient selection important-many co factors involved
  • most commonly done of a variety of surgical procedures to alleviate airway obstruction

Variable success

Do polysomnogram after surger or mandibular to see how it works

268
Q

Obesity hypoventilation syndrome-fat bicarb 48(long term respiratory acidosis-lets try to compensate), non smoker, Hct up (RBC increased…reactive from hypoxemia), pulse ox down, edema, right parasternal lift, JVD, NON SMOKER probably not COPD

A

Pickwickian syndrome-fat boy breathing disorder
Too much CO3 and too little oxygen
Many have sleep apnea
Sluggish , depressed

Can mimic copD, but PFT demonstrate restrictive not obstructive

90% will have OSA

Risk of HF, hard to get

890% pickwinian have OSA, but restrictive defect rather than

Ondine curse-fell in love with man found out he was cheating so out curse on him so he was aware of his breathing so if he forgot he would die if sleep DIE

269
Q

Symptoms obesity hypoventilation syndrome we need to do polysomnography!!!!!! Get ideas of what is going on and diagnose

A

decreased central respiratory drive

Restrictive chest , pulmonary HTN, hypoxemia,

Difficult airway, OSA

CAD, congestive HF

Difficult to position and bad vascular access

270
Q

Man sleepy during day stops breathing at night, doesn’t use alcohol, stopped smoking eight years ago, is sedentary, OBESSE

A

He’s fat

271
Q

Pink puffer

A

Emphysema thin burning so many calories as try to breathe

272
Q

Blue bloater

A

Chronic bronchitis

273
Q

Symptoms chronic bronchitis -a type of COPD-most have combo-productive cough 3 months for 2 years uncreas in volume of tissue in broncholar wall and accumulation of inflammatory exudate in the airway lumen

A

Cyanosis, crackles and wheeze, obesity, peripheral edema, CO2 retention, chronic productive cough, purulent sputum

Fat

CO2 narcosis,

274
Q

Emphysema symptoms THIN-a type of COPD-most ppl have combo-permanent enlargement of airspace’s distal to the terminal bronchioles with destruction of the bronchiole walls without fibrosis-loss of elasticity

A

Minimal cough, tachypnea and increase minute ventilation , pink skin, pursed lip breathing muscles, barrel chest, decreased breath sounds, cachectic appearance

Increase end expiratory pressure keep from collapsing so pink, prominence of breathing musculature barrel chest

Cytokines, cachetic

275
Q

Extrapulmonary COPD

A

Ischemic heart disease, HF< osteoporosis, diabetes metabolic syndrome, normocytic anemia, depression
Peripheral inflammation INFy, crp chronically elevated, serum amyloid a, surfactant up,

Skeletal muscle weakness and cachexia, at risk for lung cancer, ischemic HF, osteoporosis, metabolic syndrome

Also get chronic hypoxia and HB chronically elevated-secondary erythrocytosis**

276
Q

Dyspnea scal 0-normal ppl

A

I only get breathlessness with strenuous exercise

277
Q

Grade 1 dyspnea cycle

A

I get short of breath when hurrying on level grounf or walking up a slight hill

278
Q

Grade 2 dyspnea scale

A

On level grounf, i walk slower than people of the same age bc of breathlessness, or I have to stop for breath when walking at my own pace on the level

279
Q

Grade 3 dyspnea scale

A

I stop for breath after walking about 100 yards or after a few minutes on level ground

280
Q

Grade 4 dyspnea

A

I am too breathless to leave the house or i am breathless when dressing

281
Q

BODE-survival prediction,

A

BMI+airflow obstruction+dyspnea rating+exercise capacity (6 min walk test)

Higher worse

282
Q

BMI>21

A

0 points
<21 1 point

—-why if don’t have as much lean Boyd mass it is a problem can affect mortality in this disease

283
Q

FEV1>65% normal

A

0 points

284
Q

FEV150-64%

A

1

285
Q

FEV1 36-49%

A

2

286
Q

FEV1<35%

A

3 points

287
Q

^MWT >350 meters

A

0

288
Q

6MWT 250-349 m

A

1 point

289
Q

6MWT 150-249 m

A

2 points

290
Q

<149 m 6MWT

A

3 points

291
Q

0-2 points

A

80% 4 year survival

292
Q

3-4 points

A

67%

293
Q

5-6 points 4 year survival

A

57%

294
Q

7-10 points

A

18% four year survival

295
Q

Why get dyspnea in COPD

A

Increased dead space-increased PaCO2

Altered V/Q relationship-hypoxemia

Airflow obstruction-limits ability to meet increased demands

Reduced mechanical advantage of the diaphragm
-Hoover sign, accessory respiratory muscle use, paradoxical respiratory motion

Diaphragm flat so when breath it contracts and rams together out in periphery rib cage gets pulled in paradoxically,

Diaphragm doesn’t descend , get suck in rather than out

What Hoover sign is-

296
Q

Normally tidal flow volume loops expand in both directions during exercise. I’m emphysema, the decreased expiratory time results in more air trapping and increases the FRC, shifting the tidal flow volume loop curves to the left, a phenomenon called

A

Dynamic hyperinflation

297
Q

Asthma COPD similar

A

Weather may exacerbate
May have perennial symptoms

Exam-cough, sputum, wheeze, prolonged expiratory phase

298
Q

Differences COPD asthma

A

Complete reversibility, may have seasonal variations , may have associated ENT allergic symptoms, usually younger at onset

299
Q

Similarities COPD LVF

A

Progressive dyspnea, orthopnea

Exam-wheeze, cough, dyspnea

300
Q

Differences LVF COPD

A

PND, history of heart disease,

Exam-crackles, edema, s3 gallop, JVD/HJR

301
Q

Sama

Causes of COPD=a1at too much neutrophil elastase in lung destroy elastin early onset COPD, genes in detox of cig smoke, low birth weight, childhood, air pollution

Prevention-smoking stop causes bronchial mucous gland hypertrophy and goblet cell metaplasia with inflammatory cell infiltrate, squamous cell metaplasia, ciliary loss, SM prolif, …smoking cessation

Best prevent is stop prevent

A

Ium

Ipratropium

302
Q

Saba

Screening-not recommended in not symptomatic
Screen early onset and strong family history of lung or liver disease for aat

Diagnose-sough, sputum production and dyspnea, smoking history, laryngeal height under 4 cm most predictive of copd
(Top of thyroid cartilage and suprasternal notch), hyperinflation, barrel crest, hyperresonant percussion , distant breath sound, prolonged expiration time, Cor pulmonar, neck vein distention,

A

Ol

Albuterol

303
Q

LABA

A

Terol

Olodaterol

304
Q

Lama

A

Ium

Tiotropium

305
Q

ICS

A

Asone

Fluticasone

306
Q

ICS

A

IDE

Budesonide

307
Q

Metered dose inhaled (MDI)

A

Non breath activated-drug is released when you activate the inhaler

Breath activated-drug is released when you breathe

308
Q

Dry powder inhaled or DPI

A

Single dose device-with a single dose the patient puts a capsule int he device

Multiunit device-dose built into the device

Multidose device-dose built into the device

309
Q

Respiratory

A

Propellant free liquid inhaler creates a cloud

  • proair respimat
  • spiriva respimat
  • siolto respimat
310
Q

Mild and younger patients (FEV1>50% and age<65)

A

Doxycycline (macrolides may become the standard)

TMP-smx

Cephalosporin (ceftroxinme, cefdinir, cefopodoxine)

Advanced macrolides(azithromycin, clarithromycin)

311
Q

Sicker older patient

A

Amoxicillin-clavulunate

Fluoroquinolones(Achilles tendon rupture)

312
Q

Steroids

A

Prednisone, cheap, a range of starting doses
-1mg/kg, in practice adults are given 40-60mg/day

CHEAP

Methhylpredisolone-meh

313
Q

Indications for supplemental O2

A

PaO2<56 or SpO2<89% measure twice over a 3 week period of time

PaO2>56<60 any time with evidence of
-pulmonary HTN, CHF, erythrocytosis HcT<55%

314
Q

Gold I mild treat

A

SABA or SAMA prn; often together in same inhaler

FEV1/FVC <70% FEV1>80%
With or without chronic symtpoms

315
Q

Gold II treatment
FEV1.FVC<70%; <50%FEV1<80%
With or without chronic symtpoms

A

LABA or LAMA

Need something take once or twice a day, every 12 hour basis

Add regular treatment with one or more LABA add pulmonary rehab

316
Q

Gold III treatment severe disease
With or without chronic symtpoms
FEV1/FVC<70^; 30% FEV1<50%

A

ICS+LABA Ir ICS+ LAMA (never use ICS alone in COPD)
With or without either roflumilast or theophylline

Need to bring steroids in here. Use steroids wit LAMA or LABA. In COPD don’t just give steroid NEVER(acceptable in asthma but not acceptable in COPD)****

Add ICS if repeated exacerbations

317
Q

Gold IV verysevere disease treat

FEV1/FVC<70%; FEV1<30% of predicted of FEV1<50% of predicted pluc chronic respiratory failure

A

ICS+LABA or ICS+LAMA or ICS+LAMA+LABA

With or without roflumilast or theophylline

As long term oxygen therapy if chronic respiratory failure; consider surgical

318
Q

Pulmonary rehab

A

Exercise training, education, psychosocial training and support, nutritional support, breathing training, inspiratory muscle training and chest physical therapy, vaccination (flu, pneumococcal)

Helpful SOCIAL

319
Q

Majority COPD

A

Smokers, former, a1AT-if young

320
Q

Who should be evaluated for a1at

A

Unexplained dyspnea and cough

Young

321
Q

Diagnose chronic bronchitis

A

Chronic productive cough some days for 3 months a year for 2 successive years without another explanation (blue bloater)

Emphysema-pink puddles

322
Q

76 yo woman was fit now walks slower pace than ppl her age, episodic wheezing 70. Years. 9 year history of dyspnea , flattened diaphragm increased retrosternal space and barrel chest (increase AP) consistent with hyperinflation COPD

FVC 62%
FEV1 52%
FEV1 68%
Gold2

36 year old [rpgressive SOB-a1at

FEV 65%
FEV1/FVC 64%
GOlD moderate
MRD=1

A
Asthma-could be start at 6
Bronchiectasis sure
CHF prob not 
Chronic bronchitis ok
Emphysema 
Broad differential 

LAMA/LABA -combination

323
Q

Interstitial lung disease

DPLD-ILD-distal lung parenchyma on histopathology that is not COPD, lung malignancy, infections-always lung parenchyma, sometimes small airway, vasculature, and/or pleura—histo with inflammation and fibrosis vs granulomatous
Inflammation and fibrosis-epithelial surface injury inthe alveoli leads to spreading fibrotic change into the interstitial and vasculature, which can progress to interstitial fibrosis.

Can affect large lung area

Interstitial pleumonia vs idiopathic pulmonary fibrosis-

A

progression of interstitial changes over time in lung parenchyma, very difficult to reverse, can delay progression (reverse if hypersensitivity!)

Dyspnea, cough, crackles often describes as Velcro primarily developing in bases
Pan crackles, throughout all.

Digital clubbing (presence does not confirm and absence does not eliminate ILD)
Exercise induced hypoxemia

PFT_reduced FRC, TLC normal, FEV1/FVC ration Normal, low DLCO

324
Q

ILD FVC

Clincial diagnosis-history, physical, lab, imaging,

Progressive dyspnea:reduced exercise tolerance, and a persistent dry cough should raise DPLD . Some gradual usually-look for causes!!

A

50%

325
Q

FEV1 ILD

A

50%

Restrictive! 8590% FEV1/FVC ration

326
Q

FEV1/FVC ILD

A

90% predicted

327
Q

FRC ILD

A

45%

328
Q

RV ILD

A

35%

329
Q

TLC ILD

A

65%

330
Q

DLCO ILD

A

20%

331
Q

Causes ILD

A

Drug
Inorganic dust-asbestosis, silicosis, coal workers, pneumoconiosis, berylliosis

Lymphangitis metastases from solid tumors

Hypersentivity pneumonitis-cat, med

Radiation

Idiopathic pulmonary fibrosis-often occurs in patients over 50 but interstitial lung disease associated with connective tissue disease, sarcoidosis, lymphangioleiomyomatosis, and langerhan cell histiocytosis usually occurs 20-40

Smoking associated

CT associated-erythema nodosum

Sarcoidosis-noncaseating granuloma-erythema nodosum,

332
Q

History ILD

Radiograph-increased interstitial reticular or nodular infiltrates, often into e bases but the distribution can vary.

Smoking sure-usually COPD but can be

A

Occupation, hobby, environmental, travel, drugs both ex and non

333
Q

Evaluation ILD

A

Chest ct-can often lead to a specific diagnosis

Pft

Ana and RA—-may be informative associated with sarcoidosis and CT

334
Q

Scleroderma

A

Scleroderma
-pulmonary fibrosis-fibrosis
Pulmonary HTN-concentric fibrosis of the vessels
Aspiration-esophageal disease

Can be complaints in all

335
Q

RA

A

Causes Interstitial pulmonary fibrosis

Bronchiectasis
Pulmonary rheumatoid nodules
Pulmonary vasculitis

*Pleural disense-very low pleural glucose is characteristic

336
Q

SLE

A

Cause Interstitial lung disease

Extra-pulmonary restriction-shrinking lung syndrome
-decrease in all volumes over time, poorly Underwood and described

Pulmonary HTN

Pleural disease

337
Q

Autoantibodies in scleroderma

High resolution CT_evaluare DPLD for distribution
-lab look for CT

A

Anticentromere: 20-40%

SCL-70; 30-70; more common in ILD

Antinucleolar:10-20% but predicts the worst prognosis

338
Q

Autoantibodies in sle

Basal-IPF, asbestosis, NSIP

Upper lobe-hypersensitivity , sarcoidosis, silicosis

Peripheral-IPF, chronic eosinophilic pneumona, cryptogenic organizing pneumonia

Central-sarcoidosis, pulmonary alveolar proteinosis

Mosaic attenuation-small airways disease

A

DsDNA:550-75% (nephritis)

Ana:90-95%
Ro/la:60%/20%
Histone>90% drug induced SLE

Smith:10% white (30% aa and chinese)

Lupus anticoagulant : 20-30%

339
Q

Drug and radiation induced lung disease

Bleomycin, bulsufan -treat patients with germ cell tumors causes drug induced lung disease

Bulsulfan-causes restrictive lung disease bulsulfan lun

PD1, PDL1 inhibitors -restore bodies immune competenance

A

Chemotherapeutic agents-largest category

Amiodarone-cardiac antiarrhythmic agent dose related, dose related

Nitrofurnation-antibiotic commonly used for UTI

Radiation induced

340
Q

Radiation induced lung disease phases

PFT of DPLD-decreased volumes of all and decreased diffusing capacity

A

Early-1-3 months after
-acute

Late phase 6-12 months
-related end effect causing chronic fibrosis

Radiation recall reaction-more pneumonitis when had radiation disease occurs and u get rechallenged with something else

With newer radiation techniques it is less common

341
Q

Inorganic dusts

Lung biopsy-sometimes required to confirm a diagnosis

Smoking-respiratory bronchiolitis interstitial lung disease, desquamative interstitial pneumonitis and langerhans cell histiocytosis

CT_RA, progressice systemic sclerosis, sjorgen-autoimmune or complication like aspiration. NSIP. Focus on CT disorder treat and prevention of reflux

A

Asbestosis, silicosis, coal, berylliosis

-decades after exposure,dyspnea on exertion, dry cough, exercise intolerance. Increase in basilar and subpleural bilateral linerar interstitial markings . Pleural plaques which are often calcified. Restriction

342
Q

Acute form of hypersensitivity pneumonitis
*granulomatous

Put on antiviral and don’t get better….maybe something more going on

A

HIStoRY OF EXPOSURE

Can present as flu like. But most often occurs over time chronic.

Crackles, leukocytosis
Abrupt onset of dyspnea, cough, fever, with or without myalgia

CXR pulmonary infiltrates

Remove from agent

343
Q

Chronic hypersensitivity oneumonitis

*granulomatous

A

Pulmonary fibrosis

344
Q

IDL similar CHF

CHF and ILD-dyspnea, hypoxemia, similar chest x ray, crackles In base, pulm HTN

History difference,

A

Progressive dyspnea, exercise induced hypoxemia, cxr similar infiltrates

Exam crackles in base, may have evidence of pulmonary htn

345
Q

Differences ILD versus CHF (LVF)

Idiopathic pulmonary fibrosis-poor prognosis, dyspnea on exertion, exercise intolerance, dry cough, crackles on inspiration, imaging shows lower lung zone and subpleural linear reticular markings, volume loss, honeycomb and traction bronchiectasis. UIP on histo. No trat. Poor. Evaluate exacerbation for infection or treatable things.

A

Some specific history differences in onset and details

CXR and ct have specific differences

Differences
-clubbing, edema, s3 in LVF

346
Q

Ild different from copd

A

More rapid decline, cough non productive

347
Q

Copd different from ild

A

Slower decline with more frequent exacerbations

Weather and nsaids worsen symtpoms
Productive cough

348
Q

Treat ILD

A

Remove or treat cause

Corticosteroids remain the mainstay or treatable non IPF causes
-meh

Idiopathic pulmonary fibrosis ONLY

  • pirgenidone-antifibrotic and anti inflammatory-specific action is unknown
  • nintedanib-tyrosine kinase inhibitor target inflammatory and profibrotic factors
349
Q

Acute interstitial pneuma (Amman rich)

A

BAD
Idiopathic interstitial lung disease that is clinically characterized by sudden onset of dyspnea and rapid development of respiratory failure

Histologically characterized by diffuse alveolar damage with subsequent fibrosis

Very fast

Ham man rich
Rare, all age group, diffuse symmetrical bilateral **

350
Q

AIP not IPF (hamman rich)

A

Occurs in all age, mainly adults

No specific etiology

Pattern is diffuse, symmetrical and bilateral

NEED BIOPSY

Abrupt onset with flu like symptoms biopsy establishes diagnosis

351
Q

IPF not AIP

A

Occurs almost exclusively in adults

Often relatable to prior causative exposure

Pattern is often asymmetrical and favors upper or lower lobes**** tends to favor upper or lower ASYMMETRICAL

Granular onset, afebrile

Diagnosis based on history/clincial findings, imaging, and PFT, biopsy optional

Don’t usually biopsy

352
Q

Sarcoidosis

-splunkers caves silicosis and bat poop can get hypersensitivity pneumonitis as result of hobby.

Chronic hypersensitivity-continued inhalation

Respiratory bronchiolitis associated interstitial lung disease-present ina cuticle smoker micronodular disease

A

Most asymptomatic of mild disease

Often found incidentally on chest radiograph

Bilateral hilar adenopathy!!!! Sarcoidosis
Symmetrical chest x ray

Chest c ray i fairly symmetrical (not so with chest CT)

In a small number of ppl can be devastating disease and can lead to severe disability and death

Prednisone is treatment of choice

353
Q

Key to work up of chronic dyspnea

Dyspnea years-parasternal/lift heave and persistent split S2 -pulmonary HTN and ventricular hypertrophy right.
-not hyperinflated, restrictive, diffuse reticulat infiltrate upper lung zone. Hypersensitivity interstiital lung disease

Woman -6 month, SOB stairs, 32, shin lesion-sarcoidosis typical to have fever, painful red bumps 6 months ago (erythema nodosum), nodules, granulomas, blacks, Hillary adenopathy, cough dyspnea, chest heaviness, fever hilar adenopathy, interstitial infiltrates (nodular peribronchial), or patchy alveolar. NONCASEATING, nodular,

A

Detailed history approached in a systemic way to guide the search for the underlying cause in an efficient manner

354
Q

Thoracentesis can be deferred

Organizing pneumona=small airway bronchiolitis with granulation tissue. CLINCIALLY flu like illness and has a radiographically appearance with peripheral opacities that change over time, among other findings when a proximate cause is identified, this syndrome is BOOP

-65 yo granular progressive SOB present with exertion occasionally productive cough 30 pack history ,shipyard asbestosis …chipper exposed to more

Clubbing , restrictive, posterior crackles. Pleural plaquesw thi asbestosis on parenchyma PLEURAL PLAQUES…asbestosis.
What do????? No further testing diagnosis made. Classic example of asbestosis in shipyard worker

A

In patients with a small amount of pleural fluid and associated heart failure, pneumonia, or heart surgery (<1cm thick on decubitus radiography or ultrasonography)

355
Q

Pleural fluid amylase

A

Should be measured only when pancreatic disease, esophagealrupture, or malignancy is considered

356
Q

Omalizumab

A

Binds IgE and reduce exacerbations in patients with severe persistent asthma who have evidence of allergies.

357
Q

Side effect omalizumab

A

Anaphylaxis
Expensive

Select patients who remain symptomatic despite other therapies

358
Q

Smoking cessation

A

Most clinically effective and most cost effective way to prevent and slow the progression of chronic COPD and improve disease related survival

359
Q

Screening for airway obstruction

A

In asymptomatic patients is not recommended as there is little evidence that making the diagnosis in setting

360
Q

Metered dose inhaler

A

With proper instruction and good technique, is as effective as a nebulizer

361
Q

Home tests

A

May be inaccurate

362
Q

Pulmonary arteries

A

Deliver mixed venous blood from the RV to the pulmonary capillary alveolar membrane where gas exchange occurs, while the bronchial directly from the aorta.

363
Q

Primary cause of pulmonary HTN

A

> 25mmHg MAP during rest

Conditions causing elevation of left sided heart filing pressures or pulmonary disease(treat underling cause)

364
Q

Clincial findings pulmonary HTN

A

Mortality, morbidity,

Group 1-restricted flow through pulmonary vasculature with elevation vascular resistance

Fatigue, dyspnea with exertion , palpitations,

Advance-RV decompensation, including syncope, edema, ascites, and hepatomegaly, left parasternal lift, increased jugular a wave and pulmonic component of S2 , murmurs of tricuspid regurgitation or pulmonic insuffiency, RV s3 or s4

365
Q

Diagnose PH

A

Ok

366
Q

Common management principles in patents with pulmonary HTN

A

For condition

367
Q

Treat I PAH mPAP>25 and PCWP<15

Idiopathic , heritable BMPR2, ALK1, enfolding with or without hereditary hemorrhagic telangiectasia

A

Drug and toxin induced

Associated with ct diseases (scleroderma), HIV , portray HTN, congenital heart disease, schistomiasis, chronic hemolytic anemia

368
Q

Type II

A

Pulmonary veno occlusive disease and/or pulmonary capillary hemagiomatosis
Systolic dysfunction
Distaolic dysfunction
Valvular disease

MPAP>25 PCCWP up
Left sided heart

369
Q

Type III

A

Secondary lung disease and/or hypoxia mPAP>25 with underlying lung disease

COPD, ILD< pulmonary study, sleep disordered breathing, alveolar hypoventilation, high altitude

370
Q

Type 4

A

Chronic thromboembolic pulmonary HTN

Secondary unclear or multifactorial causes

Hematologic disordersL myeloproliferative disorders, sickle cell

Systemic disorders: sarcoidosis, pulmonary langerhans cell histiocytosis, vasculitis
Metabolic disordersL glycogen storage disease, gaucherie, thyroid

Others: tumor obstruction, fibrosing mediastinitis, chronic kidney failure on dialysis

371
Q

Ph persist even with treatment

A

Ugh

372
Q

OSA symptoms

A

Habitual snoring, witnesssed apnea, nighttime awakening with grasping or choking, insomnia, nighttime diaphoresis, ED, daytime fatigue or sleepiness, alterations in mood, neurocognitive decline

373
Q

Physical finding osa

A

Fat, large neck circumference, nasal obstruction, enlarged tonsils, narrow oropharynx, macrflossia, retro or micrognathia

374
Q

Testing OSA

A

Polysomnography-test of choice

Reduced channel polysomnography-sensitivity 80-85%, less expensive and less accurate than polysomnography but may offer increased access to diagnosis

Overnight oximetry-sensitivity 90% specificity 65% overnight ocimetry is not an accurate OSA

Serum TSH-obtain with recent weight gain increased in 2-3%
CBC_secondary erythrocytosis can be a complication of severe osa with accompanying severe hypoxemia

CXR-obtain if coexisting heart failure is suspected based on physical exam. HF can be a complication

ECG-obtain if coexisting heart failrue is suspected based on PE
Arterial gas-if obese hypoventilation syndrome is suspected to look for hypercapnia and hypoxemia

375
Q

Differential OSA

A

Central sleep apnea

Upper airway resistance syndrome
Periodic limb movements of sleep
Narcolepsy
COPD
Restrictive
GERDsinusitis
HF
Epilepsy’s
Sleep deprivation or short sleep schedule

Hypothyroidism
Acromegaly

376
Q

Treat OSA goals

A

Improve daytime sleepiness and cognitive performance and to prevent long term sequelae

377
Q

Treat osa

A

Lifestyle and CPAP

Oral devices or upper airway surgical procedures

Don’t drive until resolved

378
Q

If persists despite preventions

A

Nocturnal CPAP
-pneumaticallt splinting the entire airway, presenting collapse bc it raises intraluminal airway pressure and increases functional residual capacity.

CPAP willl increase daytime alertness, decrease HTN, and ap epic episodes

379
Q

Bad CPAP

A

Hard to use

Can get heated humidification, education, follow up

380
Q

If still can’t use CPAP

A

Bi level positive airway presssure nasal ventilation or auto-titrating positive pressure devices that modify airflow pressure to a more comfortable level.

381
Q

Mandibular advancement devices

A

Alternative therapy; however eliminate the need for CPAP in only mild to moderate

382
Q

Surgery

A

Unable CPAP. Resection or enlarged, obstructing tonsils may be beneficial in some.

Uvulopalatopharyngoplasty-alleviate obstruction of the hypoglossal space.
Variable success rates , depending on things.

383
Q

What do to document eddect of mandibular advancement device

A

Follow up polysomnogram

384
Q

Common causes of COPD

A

Emphysema and chronic bronchitis
, airflow limitation that is not fully reversible

A1 antitrypsin (too much neutrophil elastase)

Genes responsible for the production of enzymes involved in detoxification of cigarette smoke. Low birth weight, childhood illness (effect lung growth)
-tobacco smoke, occupational dist, chemical agents, air pollution

385
Q

DIFFERENTIAL for COPD

A

Asthma, bronchiectasis,CF

386
Q

Stage I GOLD

A

FEV1/FVC<70%; FEV1>80% of predicted

With or without chronic symptoms (cough, sputumproduction)

387
Q

II COPD

A

FEV1/FVC<70%; 50%

388
Q

GOLD III severe

A

FEV1/FVC<70 30%

389
Q

State IV COPD

A

FEV1/FVC<70%; FEV1<30% or FEV1<50% plus chronic respiratory failure

390
Q

Treat mild

A

SABA

391
Q

Treat II

A

Add regular treatment with one or more long acting bronchodilators; add pulmonary rehabilitation

392
Q

Stage III treat

A

Add inhaled corticosteroids if repeated exacerbations

393
Q

TreatIV

A

Add long term oxygen therapy if chronic respiratory failrue; consider surgical treatments

394
Q

Difference between interstitial pneumonia’s and idiopathic pulmonary fibrotis

A

Interstitial-inflammations Nd fibrosis pattern, it is believed that epithelial surface injury int he alveoli leads to spreading fibrotic change into the interstitial and vasculature
(UIP, NSIP, BOOP/COP)

Idiopathic-formof idiopathic DPLD. A diagnosis is important bc its poor prognosis. Dyspnea on exertion, exercise intolerance , dry cough, and crackles on inspiration. In typical cases, imaging shows lower lung zone and subpleural linear reticular markings, volume low, honeycombingand traction bronchiectasis. Histoplasma-UIP. Clincial course punctuated by acute declines due to exacerbation ofunderlying disease or overlay of infection , HF, or other comorbidity. Poor prognosis.

395
Q

UIP

A

Hallmark different stages
Starts subpleural

Pneumoconiosis, radiation injury, end stage hypersensitivity, sarcoid

396
Q

NSIP

A

Uniforminvolvement of lung parenchyma with cellular infiltration or fibrosis. Bilateral, subpleural, correlating ground glass infiltrates on CT imaging andlittle honey combing.

AutoimmuneCT

397
Q

BOOP

A

Small airway bronchiolitis with granulation tissue and organizing pneumonia

With a granulomatous pattern,T cells, macrophages and epithelium cells accumulate to form granulomas int he lung parenchyma
GRANULOMAS

398
Q

Treatment DPLD

A

Stop smoke

Supplemental oxygen

Symptomatic treatment for reactive airways or cough, maintenance of nutrition and fitness,and treatment of infections are also good.

Env exposure stop

Many get pulmonary HTN. Vasodilation agent to reduce right sided vascular resistance and pressures

399
Q

Drugs DPLD

A

Amiodarone (dose dependent-any timetoseveral years after), methotrexate (treat CT disorder)and nitrofurantoin
(Antimicrobial)

Smoking

CT associated

Pneumoconiosis-asbestos, silicon, beryllium,IPF-asbestosis (decades after sign exposure and may be progressive),

400
Q

Anti fibrotic medications for DPLD

A

?

401
Q

Usual interstitial pneumonitis UIP

A

Hallmark pattern heterogenous involvement of the lung with different stages of progression of fibrosis in adjacent areas of the lung. The disease starts int he subpleural regions and honeycombing is seen. Associated with pneumoconiosis, radiation, end state hypersensitive, advanced sarcoid,

Idiopathic pulmonary fibrosis-no cause

402
Q

Nonspecific interstitial pneumonitis

A

This pattern, there is uniform involvement of lung parenchyma with cellular infiltration or fibrosis. The process is often bilateral, subpleural, with correlating grounf glass infiltrates on ct imaging and little honeycombing. This pattern is typically seen in association with an underlying disease process such as autoimmune ct

403
Q

BOOP

A

Small airway bronchiolitis with granulation tissue and organizing pneumonia.

With a granulomatous patter, T cells, macrophages, and epithelium cells accumulate to form granules in the lung parenchyma. Granules hallmark of thess diseases but are not the sole finding and fibrotic change may be seen in the same patient. Granulomas

Well formed non caseating-sarcoid

Loosely-hypersensitivity

404
Q

Diagnosis DPLD

A

History, PE, lab, imaging, lung biopsy

405
Q

Presentation DPLD

A

Progressice dyspnea, reduced exercise tolerance, and a persistent dry cough should raise the possibilty

Gradual onset

406
Q

History DPLD

A

Meds, workplace, env exposures

407
Q

> 50

A

Idiopathic pulmonary fibrosis

408
Q

20-40

A

Interstitial lung disease associated with CT disease, sarcoidosis, lymphangioleiomyomatosis, and langerhan

409
Q

Female DPLD

A

Lemphangioleiomyomatosis

410
Q

Smoking

A

Respiratory bronchiolitis associated with interstitial lung disease, desquamative interstitial pneumonia and langerhan

411
Q

Exposure to bird

A

Hypersensitivity

412
Q

Acute onset

A

Idiopathic pulmonary fibrosis, acute eosinophilic pneumonia, COP, hypersentivity, drug induced,

413
Q

Clubbing

A

Idiopathic pulmonary fibrosis

414
Q

Erythema nodosum

A

Associated with sarcoidosis, CT diseases

415
Q

Uveitis/conjunctivitis

A

Associated with sarcoidosis, CT disease

416
Q

CXR

A

Increase interstitial reticular or nodular infiltrates, often in bases

417
Q

HRCT

A

Detail about distribution and extend of disease

418
Q

Basal predominant

A

IPF< asbestosis, NSIP

419
Q

Upper lobe predominant

A

Hypersensitivity pneumonitis, sarcoidosis, silicosis

420
Q

Peripheral

A

IPF< chronic eosinophilic pneumonia, COP

421
Q

Central

A

Sarcoidosis, pulmonary elveolar proteinosis

422
Q

Mosaic attenuation

A

Small airways disease,

423
Q

PFT DPLD

A

Decreased lung volume and decreased diffusing capacity

424
Q

Smoking related

A

Interstitial in smokers, respiratory bronchiolitis interstitial lung disease, desquamative interstitial pneumonitis, langerhans

425
Q

CT associated DPLD

A

Associated with RA< scleroderma, polymyosisis, dermatomyositis, sjorgen syndrome, and bechet

Autoimmune or from aspiration in progressice sclerosis or due to the medications she’d to modify

426
Q

Sarcoidosis

A

Granulomatous disease of unclear cause >18
Blacks

Noncaseating granulomas involving lung and other organs

427
Q

Chronic bronchitis

A

Diagnosis based on purely the patients history and symptoms. It requires a productive cough (regardless of how little or much) for 3 months out of the year for 2 consecutive years: and there is no other adequate explanation for the cough

428
Q

Asthma

A

Is a completely reversible airway obstruction. It may have multiple triggers. These may be allergic or IgE mediated, medication medicated as int he case of asprin, may be non allergic, may be made worse with changes in season, humidity, temp, exposures to irritants

It may be occupationally related. May come from exercise

429
Q

Bronchiectasis

A

Failure of the normal narrowing of the airway resulting in wider airways. Secondary to infection but may have a number of other causes

430
Q

Interstitial lung disease

A

Group of diseases that have many different causes that result in interstitial thickening, restrictive pattern on pulmonary function tests, characteristics radiographically features that often present with dyspnea and/or severe often non productive cough

431
Q

Pleural effusion

A

Sputum gets trapped between the visceral and parietal pleura. It can be from a number of different causes

432
Q

Pulmonary htn

A

Bp int he pulmonary increases due to either another disease process secondary pulmonary HTN and this is fairly common or due to inherent HTN in the pulmonary artery known as primary pulmonary HTN, which is much less common

433
Q

Common diagnosis in patients who present with cough acute

A

*Common cold or viral upper respiratory tract infection

Lower respiratory tract infections

Bacterial sinusitis

Rhinitis caused by allergens or env irritants

Asthma or copd exacerbation

Cardiogenic pulmonary edemaaspiration or foreign body

Meds (ACE i)
Pulmonary embolism

434
Q

Chronic cough cause

A

Upper airway cough syndrome

Asthma

GERD

Non asthmatic eosinophilic bronchitis

Bronchiectasis

Medication reaction (ACE-i_

Chronic bronchitis caused by smoking

435
Q

How upper viral infection cause cough

A

Protracted bronchial hyperactivity, with secondary cough lasting weeks to months

Airway cough receptors-in larynx, trachea, and bronchi and in rhinitis, rhinosinusitis, pharyngitis it is attributable to reflex stimulation from postnasal drainage or throat clearing.

-influenza a and b, parainfluenza , RSV, coronavirus, adenocirus, rhinovirus

436
Q

Influenza symptoms

A

Sudden onset of fever and malaise followed by cough , HA, myalgia and nasal and pulmonary symptoms,

437
Q

Influenza signs

A

Fever, cough, pharyngitis, rhinorrhea

438
Q

How diagnose influenza

A

Secretion culture, IF, PCR,

439
Q

Chemoprophylaxis ho gets

A

Residents in assisted living

440
Q

H1N1 symtpoms

A

Cough, fever rhinorrhea, person to person transmission

441
Q

Nonviral caues of acute bronchitis

A

Bordetella pertussis, mycoplasma pneumoniae and chlamydia

=cant diagnose pertussis treat with cough lasting more than 2 weeks during documented outbreak, known to contact a confirmed case

  • PCR
  • antimicrobial for pertussis to decrease shedding
442
Q

Pneumonia

A

Most serious cause of cough

Fever, diminished breadth sounds,

443
Q

Asthma cough

A

Acute cough

444
Q

Chronic bronchitis and bronchiectasis

A

Abrupt increase from baseline in cough, sputum production, sputum pursuance, and SOB

445
Q

Treat acute cough

A

Antitussive agents, expectorants, mucolytic agents, antihistamines, nasal anticholinergic agents.

446
Q

Indications for treatment with cough

A

Sleep disruption, painful cough, and debilitating cough

447
Q

That was all acute cough

A

Ok

448
Q

What is chronic cough

A

> 8 weeks

449
Q

Common cause of chronic cough

A

Upper airway cough syndrome

Asthma

GERD

Non asthmatic eosinophilic bronchitis

Bronchiectasis I

Ace-i

Chronic bronchitis caused by smoking

450
Q

Evaluation chronic cough

A

History, PE, chest radiography*

Smoking cessation and stop ace before more workup

451
Q

Most chronic cough in non smokers, normal chest x ray and not on ace

A

Upper airway cough syndrome

Asthma

GERD

452
Q

Upper airway cough syndrome

A

Recurrent cough that occurs when mucus from the nose drains down the oropharynx and triggers cough receptors.

Confirmed when drug therapy eliminates discharge and cough.

Postnasal drainage, frequent throat clearing, nasal discharge, cobblestone appearance of oropharyngeal mucosa, or mucus dripping down the oropharynx.

453
Q

Cough variant asthma chronic

A

Airway hyperresponsiveness and is confirmed when cough resolves with asthma meds. Cough variant asthma in 57% asthma
Can do bronchoprovocatative testing (but will also be pos for all copd)

454
Q

GERD cough

A

By aspiration
Vaguely mediated distal esophageal tracheobronchial reflex

24 hour esophageal pH monitoring

PPI if find symptom may not relieve for three months

455
Q

Nonasthmatic eosinophilic bronchitis chronic cough

A

Presence of airway eosinophilia

Inhaled glucocorticosteroid

456
Q

Cough with sputum

A

Chronic bronchitis

-stop smoking, inhaled anticholinergic agent , glucocorticoids, antibiotic,

457
Q

Bronchiectasis

A

Sputum with purulent

Chest. Radiography and CT results tram line pattern
Antibiotics based on sputum

458
Q

Smoke

A

Most have chronic cough, but don’t usually get medical attention

Stop smoking resolve 94-100%

Within 4 weeks!

459
Q

Cough caused by ACE i

A

Not dose related and may occur hours to weeks or months

Diagnose-on;y when cough stops with stop ace i

Can give angiotensin receptor blocker

460
Q

Hemoptysis

A

Acute or chronic cough

Usually from infection (bronchitis or pneumonia) followed by malignancy

461
Q

What ekse may cause the hemoptysis

A

Elevated pulmonary pressure from left sided heart failure or pulmonary embolism

462
Q

Cryptogenic hemoptysis

A

Cause not known

463
Q

What do if hemoptysis

A

Chest radiography

—-encobronchial lesion not always seen on CT do do bronchoscope too

464
Q

MASSSIVE HEMOPTYSIS

A

BLOOD LOSS GREATER THAN 200 ML.DAY. MASSIVE HEMOPTYSIS REQUIRES URGENT INPATIENT EVALUATION. AIRWAY MANAGEMENT AND VENTILATOION

URGENT BRONCCHOSCOPY

465
Q

DYSPNEA

A

Combination of symptoms of awareness of work and effort of breathing, tightness, and unsatisfactory inspirations. “My breath is short” “cant get enough air” “trouble breathing”

466
Q

MOA dyanpnea

A

Impaired ventilator mechanics

Increase in respiratory drive

467
Q

Impaired ventilator mechanics

A

Airflow obstruction, muscle weakness, decrease in chest wall compliance

468
Q

Impaired respiratory drive

A

Parenchymal or pulmonary vascular lung disease, congestive heart failure, chemoreceptor stimulation, impaired gas exchange, pregnant,

469
Q

Diagnose dyspnea

A

History and PE vitals

-if tachypnea acute muscle use, or conversational dyspnea transfer to an acute setting

470
Q

Grade 1 dyspnea

A

Not troubled by breathlessness except on strenuous exercise

471
Q

Grade 2 dyspnea

A

Short of breath when hurrying on the level or walking up a sling hill

472
Q

Grade 3 dyspnea

A

Walks slowe than most people on the level, stops after a mile or so, or stops after 12 minutes walking at own pace

473
Q

Grade 4 dyspnea

A

Stops for breath after walking about 100 yards or after a few minutes on level grounf

474
Q

Grade 5 dyspnea

A

Too breathless to leave the house or breathless when undressing

475
Q

Acute dyspnea

A

Develops rapidly over minutes to a day

476
Q

Differentiat for acute dyspnea

A

Cardiovascular-acute decrease in left ventricular function or increase in pulmonary capillary pressure (acute coronary syndrome, tachycardia, cardiac tamponade)

Respiratory-airway destruction (bronchospasm,, aspiration, obstruction), disruption of gas exchange by parenchymal disease (pneumonia , acute respiratory distress syndrome), vascular disease, PE) or ventilator pump issue (pleural effusion, pneumothorax)

Panic disorder

477
Q

Patient presents with acute dyspnea

A

Stabilization

PE
-low oxygen sat suggests asthma, exacerbation COPD, acute respiratory distress syndrome, heart failure, pulmonary fibrosis, or pulmonary vascular disease

Chest redaiography-Cause

Focal infiltrates-pneumonia

Air-pneumothorax

Basal opacity with.a meniscus-pleural effusion

Cardiomegaly and vascular engorgement-HF

478
Q

Chronic dyspnea

A

Longer than 1 month

479
Q

Top causes chronic dyspnea

A

COPD, asthma, interstitial lung disease, HF

Also maybe pulmonary vascular disorders, valvular and pericardial heart disease, anemia, and thyroid disease

480
Q

Work up chronic dyspnea

A

History

481
Q

Worsening conditions chronic dyspnea

A

Natural disease progression, medication noncompliance, and exposure to environmental or dietary factors

482
Q

Chronic dyspnea with no chronic disease

A

Cardiac related volume overload-orthopnea, edema, or exertional symtpms —look at JVD, hepatojugular refluc, murmurs s2, or s4 gallop and pulmonary and peripheral

Echo

483
Q

If no chronic disease or heart issues and chronic dyspnea

A

Pulmonary-wheezing, sough, smoking, env exposure

484
Q

What if no lung

A

Specific testing for issues

485
Q

Lung cancer major risk factors and etiology agents responsible

A

Cigarettes -mainly small cell is most bad

Head neck-alcohol, tobacco ..synergistic

486
Q

Complaints and symptoms and clincial findings in patients with cancer of lung

A

New or persistent pulmonary symtpoms, lung abnormality finding, Horner syndrome , brachial plexopathy, chest wall tenderness, extrathoracic spread (wasting lymphadenopathy, focal neurologic findings, bone tenderness, skin nodules, hepatomegaly), paraneoplastic , get chest radiograph to look for masses, lymphadenopathy, and pleural effusions, smaller lung cancers may require ct detection

487
Q

What is necessary for diagnosis of lung cancer

A

Histologic confirmation

488
Q

Sputum cytology

A

Reserved for poor pulmonary function who cant tolerate invasive procedures

489
Q

Acromegaly

A

Growth hormone releasing hormone

490
Q

Cushing syndrome

A

Adrenocorticotropic hormones (SSC)

491
Q

Lambert Eaton myasthenic syndrome

A

Proximal limb wewawkness and fatigue due to antibodies to voltage gated calcium channels (SSC)

492
Q

Hypercalcemia

A

PTH related peptide

493
Q

Hypertrophic pulmonary osteoarthropathy

A

Painful new periosteal bone growth and clubbing (adenocarcinoma)

494
Q

Hyponatremia

A

Syndrome of inappropriate antidiuretic hormone SSC)

495
Q

Pancoast syndrome

A

Shoulder pain, lower brachial plexopathy, and Horner syndrome from apical lung tumor (NSCC

496
Q

Superior vena cava syndrome

A

External compression of superior vena cava causing face and arm swelling (SCC)

497
Q

Trousseau syndrome

A

Hypercoagulable stae (most common with adenocarcinoma)

498
Q

Vocal cord paralysis

A

Entrapment of recurrent laryngeal nerve

499
Q

Horner syndrome

A

Ptosis, miosis, and anhidrosis, can be produced by a lesion anywhere along the sympathetic pathway that supplies the hand eye and neck

500
Q

Staging

A

Look for metastatic..eliminates surgery as option

501
Q

How find staging info

A

CT, PET-CT, brain imaging if neurologic symtpoms

Bone scan if bone pain

502
Q

SSC

A

Systemic at diagnosis soncidered

Sensitive to radiation and chemo

CT PET-CT and serum electrolytes, aminotransferase and lactate DH also for staging

503
Q

Where does SCC spread

A

Liver bone, brain adrenal retroperitoneal lymph nodes, pancreas and subcutaneous ST

504
Q

What is an incidental pulmonary nodule

A

Asymptomatic discrete radiographically density<3 cm that is completely surrounded by aerated lung.

505
Q

Benign pulmonary nodule

A

No growth in two years

Calcification in a diffuse central or laminar pattern

506
Q

Malignant nodules

A

> 2 cm, have speculated edges, and are located int he upper lobes. The probability of malignancy increases with age over 40, smoking, asbestos, radon

507
Q

Manage pulmonary nodules

A

Determine behavior over time and stratify risk.

Find previous radiography

508
Q

Nodule <4 mm

A

No follow up if never smoked and no other risk factors

509
Q

Nodules >4 mm

A

Follow up

510
Q

Solid nodules

A

In high risk require a consideration for immediate biopsy close interval CT scanning in another option in low risk patients

511
Q

T

A

Size

512
Q

N

A

Regional node status

513
Q

M

A

Metastatic

514
Q

Treatment 1 and II

A

Surgery
Also some III

And adjunct chemo in IB >3 vom

515
Q

Early stage non small cell if inoperable

A

Radiation but not helpful

516
Q

Stage III

A

Mediastinal lymphadenopathy

Chemo to shrink prior to surgery

517
Q

Unresectable disease

A

Chemoradiation is superior to radiation alone. Encourage stop smoking

518
Q

Metastatic inoperable IV non small cell

A

Local radiation, palliative chemo

Not beneficial with poor performance

519
Q

Decrease skeletal complications in patients with bony metastases

A

Monthly IV bisphosphonate therapy or monthly subcutaneous dosing of the RANK ligand inhibitos denosumab decreases skeletal complications in patients with bony metastases

520
Q

SSC

A

Chemo and platinum based agent and etoposide markedly improves survival

521
Q

SSC

A

MOST DIE

If tumor respond it will relapse explain that improvement is short lived

522
Q

Palliative treatment

A

Severe pain need opioids, use glucocorticoids for brain metastases to decreased intracranial edema thoracic radiation for obstruction or superior vena cava syndrome

Targeted radiation-bone pain
, nerve pain

523
Q

Cancers of the respiratory system

A

Epithelial-mucosal usually squamous cell
-paranasal sinuses, oral cavity, and nasopharyngeal, oropharynx,

Salivary gains-heterogenous and rate

524
Q

Identify the major risk factors for the development of cancer of the head and neck

A

Usually oral cavity, oropharynx, or larynx

Oropharyngeal on rise

Alcohol and tobacco!!
Synergy stick together

525
Q

Smoking cancer

A

Older than 60

526
Q

HPV cancer

A

40s or 50s

527
Q

EBV

A

All ages

528
Q

Nasopharnx

A

No early symptoms

Unilateral serous otitis media due to obstruction of ear tube, unilateral or bilateral nasal obstruction or epistaxis
Can damage CN at skull base

529
Q

Carcinoma of oral cavity

A

Non healing ulcers

Changes in fit of dentures or painful lesions

Decreased tongue or speech

HPV-neck lymphadenopathy at first sign

530
Q

Hoarseness

A

Laryngeal

531
Q

Advanced head and neck cancer

A

Severe pain, otalgia, airway obstruction, cranial neuropathies, trismus, enlarged nodes

532
Q

If enlarged nodes are located int he upper neck and the tumor cells are of squamous cell histology

A

Mucosal surface in the head or neck

533
Q

Supraclavicular node

A

Primary site in chest or abdomen

534
Q

PE head and neck cancer

A

Mucosal palpation and lymphnodes

Leukoplakia or erythroplakia -premalignant biopsy them

CT
PET

535
Q

Staging

A

Anesthesia laryngoscopes, esophagoscope ad bronchoscopy with multiple

536
Q

T1-T3

A

Increasing size

537
Q

T4

A

Invasive

538
Q

Treat

A

Localized, locally or regionally advanced disease, recurrent and/or metastatic

539
Q

Localized treat

A

T1-T2

Curative intent with surgery or radiation

540
Q

Locally or regionally advanced disease

A

Large primary tumor and/or lymph. Node metastases

Curative intent-combined modality thatpy surgery radiation, chemo

541
Q

Recurrent and or metastatic disease

A

Palliative intent

5-FU cisplatin, cabroplatin with 5-FU and cisplatin

EGFR therapies including antibodies and TKI have activity against 10%

542
Q

Pneumothorax essentials of diagnosis

A

Acute onset of unilateral chest pain and dyspnea

Minimal physical findings on mild cases;unilateral chest expansion, decreased tactile fremitus, hyperressonance, diminished breath sounds, mediastinal shift, cyanosis and hypotension in tension pneumothorax

Presence of pleural air on chest radiograph

543
Q

Pleural effusion

A

Ok

544
Q

Transudative pleural effusion

A

Atelectasis, constrictive pericarditis, duropleural fistula, extravasculr migration of central venous catheter, heart failure, hepatic hydrothorac, hypoalbuminemia, nephrotic syndrome, peritoneal dialysis, superior vena cava obstruction, trapped lung, urinothorac

545
Q

Symptoms of pleural effusion

A

Fever, dyspnea and chest pain

546
Q

Exudative

A

Inflammatory, infectious, malignant

Collagen vascular disease, intraabdominal process

547
Q

Pathophysiology pneumothorax

A

Primary spontaneous pneumothorax-absence of an underlying lung disease
-tall thin men10-30 from rupture subpleural bless

Secondary spontaneous pneumothorac-complication of disease ,

Traumatic pneumothorac-penetrating or blunt trauma

Iatrogenic pneumothorac-follow procedures such as thoracentensis, pleural biopsy, subclavian or internal jugular vein catheter placement, percutaneous lung biopsy, bronchoscopy with transbronchial biopsy, positive pressure mechanical vent

Tension p-penetrating trauma ,lung infection, cardiopulmonary resuscitation, positive pressure-pressure of air in pleural space exceeds ambient pressure throughout the respiratory cycle-check valve mechanism allows air to enter the pleural space on inspiration and prevents egress or air on expiration

548
Q

Describe management pneumothorac

A

Smal-observation, supplemental oxygen

Spontaneous primary-simple aspiration drain of air with small bore catheter
small bore chest tube to one way Heinrich valve protect against tension pneumo

Secondary, large, tension-ventilation mechanical (tube thoracostomy) under water seal drainage and suction applied until lung expands

Smoke-stop it

Thoracoscopy/open thoracotomy-recurrence of spontaneous, bilateral pneumothorac, failure of tube thoracostomy

Pneumocystis pneumonia-recurrence so hard. No best approach….

549
Q

Define mediastinal compartments and their contents

Medistinum-region between the pleural acs and has three compartments

A

Anterior-from sternum anteriorly to the pericardium and brachiocephalic vessels posteriorly.-has thymus gland, anterior mediastinal lymph nodes, and the internal mammary arteries and veins

Middle mediastinum-lies between the anterior and posterior mediastinal and contains the heart; the ascending and transverse arches of the aorta; the venae cava; the brachiocephalic arteries and veins the phrenic nerves; the trachea the main bronchial and their contiguous lymph nodes and the pulmonary arteries and veins

Posterior mediastinum-bounded by the pericardium and the tracheaanteriorly and the vertebral column posteriorly-contains descending thoracic aorta, the esophagus, the thoracic duct, the AZt go’s and hemiazygos veins, and the posterior group of medications lymph

550
Q

Anterior mediastinal

A

Thymomas, lymphomas, teratomas our neoplasms, thyroid masses

551
Q

Middle mediastinum

A

Vascular masses, lymph node enlargement from metastases or granulomatous disease and pleuropericardial and bronchogenic cysts

552
Q

Posterior mediastinum

A

Neurogenic tumors, meningoceles, meningomyeloceles, gastroenteritis cysts, and esophageal diverticula

553
Q

Squamous cell carcinoma head a neck region

A

5% of all cancers

Higher incidence of death in african descent

Men 50-60

554
Q

Risk factors

A

Smoke, alcohol, non smoke tobacco

555
Q

Field cancerization

A

As a result of structure, the entire upper aerodigestive tract is exposed to carcinogens

  • cancers may occur in any location
  • the entire area needs to be investigated when malignancy is identified to excludes second primary cancer

Look at lung!!

556
Q

Complaints of cancer head neck

A

Trouble swallowing, intermittent choking (aspiration too))

Trismus-inability to open the jaw from compression of trigeminal nerve or msucle invasion by the tumor

Ear pain-need evaluation of not responding to conventional treatment

Weight loss

557
Q

Viral cause head neck cancer

A

EBV -nasopharyngeal

HPV western—-oropharync 16 16
Younger and sex a lot of partners ..better prognossi

558
Q

Assess nutritional and performance status of patient

A

How effected a patient is

Few symtpoms vs cant work cant daily live need assistance

Dietary factors-low fruit an veg

Caretonoids-protective

559
Q

Laryngectomy

A

Remove vocal sound

560
Q

Treat cancer

A

Radiotherapy

Surgery
-laryngectomy

Systemic therapy

561
Q

Electrolarynx

A

Placed in submandibular region

Vibrates at constant pitch to allow speech

562
Q

Tracheostomy

A

Provides. Synthetic set of vocal cords for speech

563
Q

Squamous cell carcinoma types

A

Poorly differentiated, moderately, differentiated

564
Q

Worse prognosis

A

Poorly defined

565
Q

EBV

A

Undifferentiated

566
Q

Erythroplakia pre cancer

A

Red patch

567
Q

Leukoplakia pre cancer

A

White patch

568
Q

What do with nonspecific signs and symptoms in head and neck with symptoms more than 2-4 weeks

A

Thorough otolaryngologists exam

569
Q

Males or females HPV cancer neck

A

Males

570
Q

Symptoms nasopharynx cancer

A

Not really early symptoms

May cause unilateral serous otitis media due to obstruction of the Eustachian tube, unilateral or bilateral nasal obstruction or epistaxis.

Advances-neuropathies of CN due to skill base

571
Q

Carcinoma of oral

A

Nonhealing ulcers, change in fit of dentures, painful lesions. Decreased tongues mobility.

572
Q

Oropharynx or hypopharync cancer

A

Early early symptoms

Sore throat or otalgis

573
Q

HPV tumor sign

A

Lymphadenopathy first sign

574
Q

Laryngeal cancer

A

Hoarseness

575
Q

Advanced symptoms any head and neck

A

Pain, otalgia, airway obstruction, CN neuropathies, trismus, odynophagia, dysphagia

576
Q

Progressive issue swallow base in tongue, squamous cell carcinoma with no lymph node involvement and locally advanced disease-growing into adjacent structures

How treat

A

Initial radiotherapy and chemo then surgery

577
Q

Enlarged nodes in upper neck and tumor cells are of squamous cell histology,

A

Probably squamous cell from mucosal surface

578
Q

What do if have lymph node involvement

A

CT of chest and upper abdomen

579
Q

Definitive statin

A

Endoscopic examination under anesthetics

580
Q

Stage I

A

T1 tumor <2cm without extra parenchymal extension

NO No regional lymph node metastasis

581
Q

Stage II

A

T2 >2 cm but not more than 4 cm without extra parenchymal extension

N-

582
Q

Stage III

A

Tumor >4 cm

N1, metastasis in a single ipsilateral lymph node <3 cm in greater

583
Q

stave T4a

A

Tumor invades skin, mandible, ear canal, and or fascia nerve

N2

584
Q

T4b

A

Tumor invades skill base and/or pterygoid plates and/or encases carotid artery

N3

585
Q

35 yo man throat pain given antibiotics no improvement gets hoarseness, smokes and drinks, works in wood working shop

A

Occupational exposure can cause cancer wood working-inhaling things
Increase risk

586
Q

What if lymph node involvment

A

Biopsy of all suspicious appearing ares and primary site

587
Q

Treat

A

Localized, locally or regional advanced disease, and recurrent and/or metasticize

588
Q

Treat localized disease

A

Curative intent surgery

Laryngeal-radiation to preserve voice

60% survival
Most recurrence in first two year

589
Q

Treat locally or regionally advanced disease

A

Curative intent with combined therapy including surgery radiation therapy and chemo or as concomitant

590
Q

Prevent

A

Avoid exposure

591
Q

Recurrent

A

Palliative
Cisplastin with 5-FU

EGFR therapies, antibodies, TKI

592
Q

Complications of treating dad and neck cancer

A

Extent of surgery

Mucosistis, dysphagia

Xerostermia, loss of taste, decreased tongue mobility, second malignancies, dysphagia and neck fibrosis

Chemo-myelosuppression vomit nephrotoxicity

Mucosa-malnutrition dehydration

593
Q

Lung cancer top three causes

A

Smoking smoking smoking

Second hand

Radon

Coal tars

Agricultural farmers

594
Q

Majority lung cancer

A

Non small cell

Rest are small cell

595
Q

Prevention

A

Stop smoking

Give retinol, B carotene, N acetylcysteine, and selenium

596
Q

Screening

A

Low dose computed tomography scans to screen for early stage in former or current smokers

597
Q

Diagnosis lung cancer

A

Hemoptysis, pulmonary infections, dyspnea, cough, chest pain

Abnormal lung finding-primary tumor

Intrathoracic spread-hoarse voice, Horner syndrome, brachial plexopathy, chest wall tenderness

Extrathoracic spread (wasting, lymphadenopathy), paraneoplastic syndromes, bone tenderness, masses, pleural effusions, CT

598
Q

Bronchogenic carcinoma

A

Small cell

Non small cell

599
Q

What need to diagnosis

A

Histology confirmation

600
Q

Pancoast

A

Superior sulcus tumor invade brachial plexus

Shoulder pain paresthesia C7-T1

601
Q

Horner

A

Ipsilateral anhydrosis pupil constriction due to stellate ganglion

Psosis, ahydrosis, superior sulcus

602
Q

Hypertrophic pulmonary osteoarthropay

A

Clubbing of distal phalanges and hypertrophy of joints

Arthralgias, synovitis, and

Facies furrowing of brow!!

Painful, ner periosteal bone growth and cladding (adenocarcinoma)
Hypoxemia…

603
Q

Superior vena cava

A

Extrinsic compression of SVC compression of by mass, adenopathy

Distention of superficial veins and edema of face and neck

Face and arm swelling

604
Q

What do

A

1.Chest x ray, guide thinking

Will see node if >2 cm in size

  1. CT see mediastinum, lung arenchyma, liver,

MRI-more expensive and no better DONT

PET_when fused with CT, gives higher predictability for ancer vs benign disease oK USE
———fluoridinated glucose look for areas of increased uptake, if malignancies take up glucose more bc cancer more metabolically active

605
Q

Sputum cytology

A

Screening…positive 60-90% of patients with lung cancer

Bronchoscope has replaced-can see stuff down to segmental bronchi, can collect and evaluate….required if hopeful of curative

606
Q

Mediastinoscope

A

Can see hilum and mediastinal structure for tumor resection…do it if thinking of remove to make sure we know

607
Q

Diagnose

A

Fine needle aspiration

Done with radiograph or CT insert into tumor ..good for peripheral lung tumor

Risk of pneumothorax..

Central-croncospocy
FNA-peripheral

608
Q

SSC confined to one side, limited ok

A

Not extensive

15-25% cure

609
Q

Extensive SCC

A

95% die in few years

610
Q

Blood sputum in smoker

A

CT scan see if peripheral or central

Central-bronchoscopy

Peripheral-fine needle aspiration

611
Q

Tension pneumothorax

A

Mediastinal shift

Can get in asbestosis

612
Q

Hydro pneumothorax

A

See water line

613
Q

Similarities pneumothorax or pleural effusion on exam

A

Sausculataion

Absent or diminished breath sounds

614
Q

Differensions pneumothorax and pleural effusion

A

Percussion
-hyperresonant in pneumothorax, dull in pleural effusion

Auscultation
-positional changes of breath sounds
No change in pneumothorax
May improve in effusion

615
Q

Causes of pneumothorax

A

Spontaneous-young men

Traumatic
-post procedural, direct trauma

Disease related
-numerous diseases

616
Q

Exudate

A

If any of the following
-pleural protein/serum protein>.5

Pleural LDH/serum LDH?.6

Pleural fluid LDH>2/3 upper limits of serum LDH in the lab doing the measurement

617
Q

Low pleural glucose

A

Parapneumonic effusion

Malignant effusion

Tb

Hemothorax

RA

618
Q

Pleural white cells

A

Normal pleural space

-macrophages 75% lymphocytes 25%

619
Q

Disease of pleural white cells

Increase eosinophils

A

Increase eosinophils>10%

Most often due to air in the pleural space

Idiopathic parapneumonic

Malignancy

620
Q

Pleural white cells lymphocytic effusion

A

Malignancy

Tb

621
Q

Transudate

A

LVF, CHF

Other
-misplaced central line, massive cirrhosis, nephrosis

622
Q

Exudate

A

Everything else

623
Q

Manage chronic pleural effusion pleurX

A

Indwelling catheter in pleural space allowing for at home drainage

624
Q

Pleurodesis

A

-closes potential space between parietal and visceral pleura
-talc, tetracycline others
Through thorascope on in IR

625
Q

What are mediastinal disease

A

Masses, inflammation/infection. Air or fluid collection

626
Q

4 t of the anterior mediastinum

A

Thymoma

Teratomas

Thyroid masses

Terrible lymphoma-well there can be B cell lymphomas with mediastinal masses, as well as Hodgkin lymphoma

627
Q

MIDDLE MEDIASTINAL MASSESS

A

VAC

VASCULAR masses, adenopathy, cysts-pleuropericardial, bronchogenic

628
Q

Posterior mediastinal massess

A

Nerves and guts

  • neurogenic tumors,
  • meningoceles, meningomyeloceles
  • gastroenteritis cysts and esophageal diverticula
629
Q

What causes pleural effusion

A

Increased